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Resumo
Estudos em biologia já se caracterizam pela disponibilidade de grandes quantidades de da-
dos, estando além da capacidade humana de compreendê-las sem auxílio computacional.
A análise desses dados tem o potencial de identificar diferenças entre espécies e ampliar o
nosso entendimento da sua relação filogenética. Neste trabalho apresentamos a extensão
de um método de comparação de grupos genômicos via análise de enriquecimento, for-
malizando e melhorando a sua eficácia, generalidade e escopo. Nossa proposta expande o
trabalho anterior ao permitir análises de grupos arbitrários de genomas, compatibilidade
com KEGG Orthology, GO e outras, incluindo ontologias definidas pelo próprio usuário.
A metodologia foi avaliada em experimentos que permitiram concluir que ela pode ser
usada para formular novas hipóteses biológicas e que ela é computacionalmente escalável.
Abstract
Biological studies take advantage of the huge data availability, where the amount of in-
formation stored is beyond human’s ability to interpret it without computational tools.
The analysis of these data has the potential to identify differences between species and
widen our understanding of their phylogenetic relationship. In this work we present the
extension of a comparative method between genomic groups through enrichment analysis,
formalizing and improving its efficacy, generality and scope. Our proposal expands the
previous work by allowing comparison of arbitrary genomic groups, compatibility with
KEGG Orthology, GO and others, including user-defined ontologies. The methodology
was evaluated in experiments that allowed to conclude that it can be used to formulate
new biological hypotheses and that it is computationally scalable.
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Chapter 1
Introduction
1.1 Background
There are many questions in Biology regarding how each species differ from each other
and how they acquire new features, such as pathogenicity and resistance to environmental
factors. Often, these questions focus on which biological factors and mechanisms are
involved in these features. Classical examples include: how domesticated lineages differ
from wild and laboratory ones, what’s the genomic signature of certain parasites and which
mechanisms are essential to survive in their niche. Similarly, these questions may concern
systemic relationships, such as which mechanisms are lost as another one is promoted,
and by how much [1].
These questions can often be transposed as a comparison between two biological
groups: one with a character in question and another without. The description of the
differences and similarities of both groups, when not an immediate answer to the question,
can provide important clues about the character that differentiates them.
Supporting this approach, there’s a huge amount of functional annotations of genomes
published and in rapid expansion, result of the increasing speed and cost efficiency of new
sequencing methods, as well as the presence of tools for automated annotation [2, 3].
They serve as a base of comparison between genomes with clear biological meaning, being
useful to evidence the interactions and roles those mechanisms take in a given character.
Surprisingly, despite the huge amount of annotated genomic data available, there’s
an scarcity of formalized methods able to use this functional annotation for comparative
analysis, despite indications that their number can be used for comparison between organ-
isms [3, 4] and that the characters of an organism can experience gains in robustness and
viability with the accumulation of related genes and proteins [5, 6]. Current comparisons
are made mainly by juxtaposing identified differences with findings of published articles
from a chosen organism, limiting the scope to the local differences emphasized by each
study and to a small number of genomes, feasible to a manual approach.
11
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1.2 Motivation
Processing large amounts of annotated data requires methodologies to analyze them quan-
titatively and to take advantage of their ability to provide clear biological meaning, prefer-
ably also informing how each biological factor interact with each other. Moreover, scala-
bility and robustness are desirable due to the growing amount of functional data and the
likelihood of rerunning previous tests to update annotations and add newly annotated
genomes.
Two former studies establish the biological validity of a functional comparison between
genomes and its reliability, ensuring the results are reproducible. For that, they adapted
the enrichment analysis (see 2.2.1), a well known method in transcriptome studies, for the
functional comparison of how genomic elements, mostly genes, are shared across genomes
[3, 4].
The main motivation for this work is to expand the ways in which their methodology
explores the information generated throughout the analysis. Besides finding which terms
represent the differences between genome annotations, it is of interest to know how these
annotations differ, why a term is significant and how these terms are related. This can
reveal subgroups of organisms with different functional patterns, offer quantitative details
about the differences between both groups and lead to the formulation of new biologically
meaningful hypotheses.
Additionally, an implicit concern in these two former experiments [3, 4] was the trade-
off between performance and generality of the comparison, as they couldn’t determine
whether the method would remain scalable if allowed to compare arbitrary groupings of
genomes. As neither study formalized an algorithm for genome comparison to evaluate
the method’s efficiency, they applied restrictions to ensure the running in a reasonable
time. The study that inspires this dissertation in particular, KOMODO (Kegg Orthology
enrichMent Online DetectiOn) [3], placed many important restrictions to guarantee a good
performance when analyzing multiple genomes at once, such as restricting the groups to
predefined taxa. In doing so, it also reduced the generality of the method, limiting the
possible criteria for which to compare genomes.
In this work, we formalize and expand the methodology employed by those previous
works, offering a computational framework to allow scientists to perform first-principle
comparative genomics. Our method innovates in several aspects, such as the ability to
organize and reuse information, how much information (in type, quality and quantity) it
provides for the formulation of new hypotheses, among many others. This framework sup-
ports the general version of the method proposed by Lobo et al. [3], ensures its scalability
and enables the use of additional tools to expand the ability to provide meaningful biolog-
ical information, while offering additional measures to investigate the biological question
under analysis.
Chapter 2
Basic concepts
This chapter is dedicated to explain the concepts applied in this dissertation.
2.1 Ontologies and genome annotation
Ontologies are, in Computer Science, structured representations of a given body of knowl-
edge, commonly used to embody the results of academic research and to offer an opera-
tional method to put theory to practice in database systems. They specify the relevant
concepts of a field and its relationships, providing a formal vocabulary and clear oper-
ations to manipulate them [7], and mirror a particular facet of the data or phenomena
being represented.
More specifically, an ontology is composed by concepts, whose identifier and definition
is called term (e.g. identifier GO:0009405 with definition ”pathogenesis” being the term for
the concept of the ability to inflict a disease), and, optionally, by predefined relationships
between terms. A vocabulary is the universe of terms of an ontology, and the relationships
between terms form the syntax of the vocabulary. Additional definitions may appear
depending on the ontology’s specific structure; for Gene Ontology, we will present the
definition of ”ancestor term” in Section 2.1.1.
For biological sciences, the importance of ontologies is in the need to annotate genomic
elements [8]. An annotation is defined as a standardized explanatory note added to
known genomic elements, such as genes and proteins. To standardize it, they borrow the
definition of ontology from the Computer Science and formalize the field’s terminology
in a controlled vocabulary, using its terms as the explanatory notes when annotating
genomic elements. This allows any annotated element to have its known functions and
properties unequivocally understood by any research group or computational tool.
One particular importance of ontologies is the support for data synthesis and inference.
Genomic elements annotated with different terms may share a common attribute, which
is detectable if those terms share a relationship with a common term, representing that
attribute. As such, the structure of the ontology can aid the detection of subtler patterns
between genomes and their elements that may be otherwise untraceable.
13
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Figure 2.1: Example of Gene Ontology’s structure for apoptosis, or self-inducted cellular
death. All terms (vertices) above the one highlighted are its ancestors terms, representing
more generic attributes or functions. The caption shows all relationships between terms
predefined in the ontology, with only the ”is a” relationship present in this particular
example and meaning term A is considered to be a more specific case of term B. Image
obtained from http://www.ebi.ac.uk/QuickGO
2.1.1 Gene Ontology
The most known biological ontology is the Gene Ontology, or GO, dedicated to represent
the known attributes of genomic products within three categories: Biological process,
Cellular components and Molecular functions [9]. Each category is a directed acyclic
graph (DAG), in which each vertex represents a term of the ontology (ex: GO:0030313 ”cell
envelope” and GO:0006915 ”apoptotic process”) and each edge represents a relationship
between terms. The DAG nature of GO follows an hierarchy in which terms containing
more general concepts are considered above terms with more specific ones, and are the
receiving end of ”is a” relationships.
This ontology contains an additional definition, the ”ancestor term”. Each term pre-
ceding another in the hierarchy is called an ”ancestor term” of that one and represents
a more general concept than the ones below it. Examples in Figure 2.1 are all terms
above ”apoptotic process”, like ”programmed cell death” and ”biological process”, all de-
fined as ancestor terms to it. This is used when seeking a pattern between multiple terms
though a common ancestor term. An example is shown in Figure 2.1, with the possible
relationships of the ontology in the caption.
Each genomic element can have multiple GO terms annotated to it. They are stan-
dardized as the most specific terms in the ontology that represent the functions and
properties of that element; ancestor terms to them are also applicable, but omitted when
a more specific term is valid. Therefore, an element annotated to, for instance, ”apoptotic
process”, is also defined as a ”programmed cell death” and all other ancestor terms (Figure
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2.1), but won’t show them in the annotation.
Historically, the objective of GO was to unify the description of genome products,
in a context of the discovery of their high conservation among fundamental processes,
over many evolutionary distant species [9]. In particular, it was glimpsed the creation
of a knowledge base around this conservation to easily infer the biological processes of
less studied organisms. With many discoveries in a short period of time, many research
groups perceived that the lack of a standard terminology would become a barrier to
the identification of conserved processes and adhered to a unification project, the Gene
Ontology, which continues under revision to keep it updated with recent discoveries. It
has been extensively used by many major research groups and bioinformatics tools since
then.
2.1.2 KEGG - Kyoto Encyclopedia of Genes and Genomes
An ontology is available within KEGG (Kyoto Encyclopedia of Genes and Genomes), a
biological database for interactions among known proteins and molecules within metabolic
pathways [10]. In these pathways, the product of one gene-mediated process acts as the
substrate of, leads to, or regulates the next process. Relationships in pathways repre-
sented in KEGG indicate which processes regulate or precede another. An example is
shown in Figure 2.2. A central element of KEGG database is the KEGG Orthology (KO)
entity, whose central concept is the homology. Two genes are homologous if they share
ancestry due to gene duplication within a genome (paralogy) or due to a speciation event
(orthology).
The structure of KEGG is different from the Gene Ontology in that KO terms do not
form an hierarchy between themselves. No KO term is an ancestor term of another, as
they’re not intended to express the biological functions themselves. As such, the definition
of each group is independent of others. While the KEGG Orthology possesses a hierarchy,
the KO terms are all in a single level. The other levels are classifications and references
to other databases, and do not appear in the genome’s annotation.
There are particular advantages of using ontologies that represent ortholog genes for
comparative genome analysis. They tend to have similar or equivalent functions [11],
which makes them useful to investigate evolutionary histories among species. Moreover,
because ortholog genes are, by definition, found in different species, they can indicate
which processes are common or dissonant between genomes. The ontology is also useful
to detect when a species lack certain nodes of a metabolic pathway and, therefore, triggers
different events and mechanisms.
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Figure 2.2: Example of the KO ontology for the process of apoptosis. Each rectangular
vertex represents a known set of ortholog genes with a common function, mediating a
specific biological process. The highlighted vertex p53, or K04451 term, represents the
ortholog genes that codify the tumor suppressor p53 protein. If not present, inhibited or
inactivated, the apoptosis can’t happen through the ”Death Genes” path. Image obtained
from http://www.genome.jp/kegg-bin/show_pathway?hsa04210
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Figure 2.3: Comparison of two distributions, each representing the data from the hy-
potheses of a significance analysis. Their difference is evaluated by a statistical test, such
as the Fisher’s Exact test, to determine if both are distinct enough to reject the null
hypothesis. Axis x is the number of standard deviations, axis y is the probability density
function (p.d.f.), the relative likelihood of a value. Higher absolute standard deviations
of the null hypothesis are considered more extreme probabilities. P-values are calculated
as the area of the null hypothesis equal or higher than (i. e. at least as extreme as) the
observed data, indicated in orange in this figure.
2.2 Significance analysis
Significance analysis is an evaluation of whether the observed effect of a stochastic (non-
deterministic) event resulted from chance alone, rather than from an investigated factor.
This is done by comparing the dataset against a background dataset or distribution, which
portraits our expected event in absence of the investigated factor, acting as a control
group. If there is no difference when comparing test and background distributions, we fail
to reject the hypothesis that the observed effect came from chance alone, within a given
margin for doubt.
To evaluate the significance of a difference between two datasets, we formulate a null
hypothesis and an alternative hypothesis, which carries distinct assumptions about the
stochastic event. The null hypothesis assumes the absence of the investigated factor, with
any difference between the datasets coming from chance alone. The alternative hypothesis
represents the presence of the investigated factor causing an actual difference between the
datasets. By comparing both hypotheses, we evaluate the likelihood of the null hypothesis.
The objective is to correctly determine if the null hypothesis is false, and reject if it’s the
case. If it rejects a true null hypothesis, the result is called a false positive, or Type I
error.
A statistical test is chosen to evaluate the likelihood of the null hypothesis and to
provide a significance value, known as p-value. It measures the probability of a value
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equal or more extreme than the observed data (Figure 2.3) under the null hypothesis, is
restricted to the [0, 1] interval and describes the evidence against the null hypothesis. Low
p-values indicates that the situation observed is an extreme case under the null hypothesis,
suggesting it is unlikely to be true.
To define whether the p-value indicates that the null hypothesis should be rejected,
a confidence threshold α ∈ [0, 1] is chosen beforehand, representing what is considered a
reasonable margin for doubt. If the p-value is below the threshold, the evidence against
null hypothesis is considered high, or beyond a reasonable doubt. The null hypothesis is
then rejected and the result is considered significant.
Among the statistical tests, three are employed in this project: the Fisher’s exact test
[12], the Kolmogorov-Smirnov test (or KS test) [13] and the Wilcoxon-Mann-Whitney test
[14]. They measure different aspects of the data distribution and have differing levels of
robustness to outliers, helping to interpret the results. By comparing for which tests a
term was significant, it is possible to infer, for instance, if that term represents a general
mechanism or if it may have a subgroup with high representation in the dataset.
Of these statistical tests, Fisher’s test is one of the most common in the scientific
literature. It evaluates the data relative to the null hypothesis of independence under a
hypergeometric distribution, which describes the chance of k successes in n draws without
replacement:
p =
(
T1+T0
T1
)(
B1+B0
B1
)(
n
T1+B1
) (2.1)
where:
- T1 is the number of successes in the treatment set, called Test group
- B1 is the number of successes in the control set, called Background group
- T0 is the number of failures in the treatment set, called Test group
- B0 is the number of failures in the control set, called Background group
- n = T1 + T0 +B1 +B0
The Fisher’s exact test has low robustness to outliers and is more sensitive to mag-
nitude changes than the other two tests. This means it can both indicate a notable
magnitude gain in the test group (traditionally called treatment set) or be skewed by a
subgroup with a particularly high representation in the dataset.
Older applications use the Chi-squared test instead due to the ease of calculation,
requiring less computational power. It assumes the null hypothesis follows a Chi-squared
distribution (description of the sum of squares of k independent variables) and provides
an approximation of the result a Fisher’s exact test would obtain by evaluating two
proportions, pA = T1/T0 and pB = B1/B0, to test two hypotheses: H0 : pA = pB and
H1 : pA 6= pB [15]. Nowadays, most applications replaced it for the Fisher’s test due to
the increased computational power available.
Modern implementations of the Fisher test also alleviate the problems of the naive
implementation of a hypergeometric probability, which requires a total of 2n operations
and is prone to overflow. One method is to perform selective division between the factorials
to simplify the numerators and denominators, reducing the number of operations to 3(B1+
B0) or lower. The p-value is calculated as the sum of p from all data at least as extreme as
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the observed (see Figure 2.3), with a final complexity of O(T1 ∗ (B1+B0)) or O(T0 ∗ (B1+
B0)), depending on which extreme (tails of the null distribution) is evaluated. There are
methods proposed to reduce the number of extreme cases to consider, reducing, but not
eliminating, the factors T1 and T0 [16].
The Kolmogorov-Smirnov test, or KS test, checks for equality of two samples, with
the null hypothesis being that they have the same empirical probability distribution. Its
statisticD is calculated by the largest difference between the two distributions at any point
in their cumulative distribution function (Equation 2.2). It has the advantage of being
sensitive to changes in location and shape of the distribution, and being distribution-free
if it’s continuous and univariate. It has a linear implementation O(m), where m is the
size of the sample [17].
Dn = supx|Fn(x)− F (x)| (2.2)
Because the KS test measures the difference in the cumulative distribution function
of the two samples and is sensitive to changes in location and shape of the distribution, it
is useful to investigate whether the samples have differing distributions, even when other
statistics (e.g. mean) suggest them to be identical.
The third test, Wilcoxon-Mann-Whitney, is also distribution-free and checks whether
one of two independent samples is stochastically greater. Its statistic is based on the sum
of ranks, measuring the ordering of the data rather than the magnitude of each individual
element. It has an O(m2n) implementation [18], where m and n are the sizes of the
samples X and Y (Equation 2.4) and pvalue calculated as:
p(m,n, k) := P0(Mm,n ≤ k) =
k∑
s=0
P (Mm,n = s) (2.3)
, where
Mm,n :=
m∑
i=1
n∑
j=1
1Yj<Xi , 1Yj<Xi =
{
1 if Yj < Xi
0 otherwise
(2.4)
The Wilcoxon-Mann-Whitney test is more robust to outliers than the Fisher’s exact
test, as it does not measure magnitude changes directly. Since it measures whether one of
them is stochastically greater, or more likely to randomly return a higher value than the
other, it is a better test to identify more general changes in the distribution, even when
the magnitude of the change is small.
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Figure 2.4: Enrichment analysis diagram. Genes are grouped with others annotated to
the same term. Each term’s representation is measured within the alternative and the
null hypothesis. The significance is then tested to identify which terms can have the null
hypothesis rejected, given a chosen confidence threshold. Values in the figure are merely
illustrative.
2.2.1 Enrichment analysis
Enrichment analysis is a type of significance analysis applied to genomic research, usually
used to extract biological meaning from a list of genes or proteins. It identifies which
known biological mechanisms are significantly more or less present in a list by finding the
annotation terms appearing more or less frequently in this list than expected by chance
alone [5].
In high throughput genomic/transcriptomic studies, enrichment analysis describes
which functions are differentially represented between two conditions among a list of
genes from one organism. The method consists in grouping all genes annotated to each
term of the chosen ontology and comparing their frequency to a null hypothesis. If the
difference observed between the two hypotheses is significantly superior for the test group
(or treatment set), that function is said to be differentially represented. This process is
illustrated in Figure 2.4.
Enrichment analysis has the advantage of being able to detect subtle systemic changes
because of the grouping of genes around their functions, translated as ontology terms [5].
A small difference among multiple genes related to the same function can compound a
difference comparable to over-expressed genes. Additionally, because it maps functions
to terms from a known ontology, the results can be interpreted in terms more familiar to
the researcher and may help identify biological themes relevant to that event.
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2.2.2 Multiple hypothesis testing
When testing multiple hypotheses using the same data, the probability of having a false
positive increases due to each of them having a separated margin for doubt [19]. The prob-
ability that none of the significance results will be a Type I error decreases as expressed
in Equation 2.5:
P (ETypeI = 0) =
n∏
i≥1
pi∈[0,1]
(1− pi) (2.5)
The control of these occurrences is commonly done in order to limit the probability
of any false positive below a confidence threshold (Familywise Error Rate, or FWER), or
to limit the number of expected false positives among the comparisons (False Discovery
Rate, or FDR). Both methods of control are known as multiple hypothesis correction and
are dedicated to minimize the expected error in the multiple hypothesis testing scenario.
It is represented in the form of a qvalue, or corrected pvalue. If the threshold is set to
α < 0.05, or less than one expected error for every twenty comparisons, all q-values below
that threshold are considered significant and a list of 60 of such results would have less
than 3 expected false positives in the case of FDR.
Historically, FWER methods showed low statistical power for genomic studies, often
returning no positive result even for medium-sized problems and causing some practi-
tioners to neglect the use of multiplicity control [20]. FDR methods were developed to
increase statistical power by relaxing the criteria of control to the expected number of
false positives, rather than the chance to have even one false positive. It has been rec-
ommended when a controlled presence of Type I errors doesn’t invalidate the final result,
which is often the case for exploratory studies.
2.2.3 Effect Size
Effect size, defined as d, is a statistical parameter that measures the difference between
two groups, or the magnitude of an effect. It is defined as the difference between two
means divided by the standard deviation of the population (Equation 2.6); when not
possible to know the latter, the standard deviation is estimated from the control group
[21].
d =
µt − µc
σ
(2.6)
µt: mean of test group (treatment set)
µc: mean of background group (control set)
σ: standard deviation of the population
It is employed to offer a comparable measure of effect between experiments, as to
distinguish the impact and size of the observed effect. It offers additional information
to significance values, as low p-values, or q-values, don’t necessarily mean that the effect
observed isn’t small. Rather, it measures how expected by the control sample the effect
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observed is. The significance value is affected both by the magnitude of the effect and by
the sample size; smaller samples require a larger difference to be considered significant.
As such, identical p-values from different experiments can have a considerable difference
in the measured effect.
Interpretation of the effect size’s absolute value may vary depending on the field of
research. Some fields adopt a 0.8 as a large effect size due to historical reasons, but usually
depends on which values are most common [22].
2.3 Bootstrapping
Bootstrapping is a method to evaluate how well a sample’s statistic (e.g. mean) estimates
its population’s statistic, where a statistic is any measure of an attribute of a group,
(e. g. mean, median and variance), a population is the group whose statistics we want
information about, a sample is a subset of the population from which we try to infer a
statistic and a sampling distribution is the probability distribution of a statistic among
random samples of a population [23].
This method is commonly applied in biological studies to measure the uncertainty of
a statistic and, as a result, offer a margin of reliability or confidence for an inference.
This concept is applied in other methodologies within Biology, such as in the creation of a
consensus phylogenetic tree [24, 25]. The method works on the premise that the sampling
distribution in the population is similar to that in its samples and can be modeled from
them. As such, the sample can provide information about the statistics in the population,
such as its confidence interval and stability.
To obtain the sampling distribution, the original sample is sampled with replacement
to produce resamples of the same size. This is done a number of times large enough to
obtain the desired statistical power. From the resamplings, we can obtain the sampling
distribution in the sample and use it to model the one in the population. This model
estimates properties of the sample’s statistics regarding the population.
The idea of being able to extract additional information from a sample by resampling
is analog to a fractal image: the same pattern observed in the larger scope is seen in its
parts recursively. By evidencing and studying the patterns of these parts, it’s possible to
estimate the pattern of the larger image. Similarly, a sample contains patterns coming
from the population, which are informative of the sampling distribution. This information
can be used to establish an analogy between the sampling distribution in the sample and
in the population.
2.4 Correlation coefficient
Correlation coefficient R is a measure of how precisely the variation of one variable x
explains the variation of a second variable y. It is employed to search for dependency
relations that may explain the behavior across variables, possibly finding a casual relation
between them. It is limited between values R ∈ [−1, 1]. A value close to 1 indicates high
direct correlation, while values close to -1 indicate high inverse correlation.
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A high correlation coefficient doesn’t implies a casual relation between two variables,
because two independent variables can be correlated to a third one instead, or present
such behavior by chance. Any possible cause behind it must be proved by other meth-
ods. Additionally, the coefficient is subject to the assumptions of the evaluation method,
similar to the case for the significance tests. To cover more than one assumption, three
in particular are used in this project: the Pearson Correlation Coefficient (PCC), the
Spearman’s rank Correlation Coefficient (SCC) and the Kendall tau rank Correlation
Coefficient (KCC) [26, 27].
PCC measures if two variables follow a linear function, having a negative value if the
angular coefficient is negative. Furthermore, the amount of the variation of y explained
by x is equal to the square of the coefficient, R2. As such, a coefficient R = 0.8 means x
explains for 64% of the variation of y.
SCC measures how well two variables follow a monotonic function, regardless of its
linearity. The evaluation is done by ranks: for variables x = {x1, x2, ..., xn} and y =
{y1, y2, ..., yn}, the orders x′i ∈ {1, 2, ..., n} and y′i ∈ {1, 2, ..., n} are attributed to each
value and the coefficient ρ is given by:
ρ = 1− 6
∑
(x′1 − y′i)2
n(n2 − 1) (2.7)
in which n is the size of the sample. This parameter is able to detect non-linear corre-
lations, such as exponential ones, and is robust to outliers, as seen in Figure 2.5. This
allows to identify cases that the Pearson Correlation Coefficient may result in low values
despite the presence of a monotonic correlation in variation.
KCC measures the association between two variables in terms of concordance between
ranks: for two variables x = {x1, x2, ..., xn} and y = {y1, y2, ..., yn}, the orders x′i and y′i
are given to each value and a concordance is said to happen if x′i and y′i show the same
relationship (larger, smaller) between themselves as x′j and y′j, i 6= j. The tau coefficient
τ is given by:
τ =
concordant pairs− discordant pairs
n(n− 1)/2 (2.8)
This can identify cases when a few outliers can reduce the value of a Pearson Coefficient
Correlation due to the loss of linearity, but still maintains the same rank relationship, or
when the ranks are preserved in a nonlinear function.
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Figure 2.5: Correlation example comparing PCC and SCC. Spearman’s method results
in coefficient 1 as long as the two variables follow a monotonic function, regardless of the
linearity.
Chapter 3
Related Works
The comparison of two groups of genomes is made through functional annotations: given
genomic elements, such as genes and proteins, annotated to an ontology, we look for which
of the terms of the ontology are significantly enriched or depleted when comparing the
two groups.
An initial work for functional genomic inference was presented by Cai et al. [4], which
adapt the enrichment analysis to compare two genomes at functional level. Until then,
functional comparison was based on term count, fold change or frequency percentage
in each genome, without accounting for variations from chance alone. The enrichment
analysis, traditionally used for expression data, was proposed for functional annotation
between two genomes as well. With that, the authors offer a control of false positives when
comparing term differences between two organisms and evidence the need for statistical
rigor, establishing an objective and quantifiable criteria for the comparison.
Their algorithm is shown in Algorithm 1. Its idea is to count, in genomes A and
B, how many genomic elements are annotated to a GO term (xA and xB) out of the
total number of genomic elements (NA and NB), and use these numbers in a chi-square
test to evaluate significance. But, since ancestor terms can also reveal patterns between
GO terms, the algorithm searches for them and counts each ancestor term only once per
genomic element (union operation at lines 8 and 15). After the chi-square test, it follows
with a multiple hypothesis correction due to the thousands GO terms compared. With
that, it establishes a statistical comparison between two genomes based on the number of
genes.
Later, Lobo et al. [3] adapted the method employed by Cai et al. to compare two
groups of genomes, without restricting the number of genomes to compare. The tool was
named KOMODO (Kegg Orthology enrichMent-Online DetectiOn), dedicated to study
the functional differences among biological taxa. Specifically, KOMODO adapts the en-
richment analysis approach to detect KO terms (groups of ortholog genes) significantly
and differentially frequent between monophyletic taxa, defined in Biology as a group
composed by an ancestral species and all its descendants (Figure 3.1).
KOMODO uses, also without computational formalization, the algorithm in 2, with
four important differences regarding its antecedent. The first is the comparison of two
groups of genomes, rather than of two individual ones, in the form of monophyletic taxa.
This allows the functional comparison to answer more general biological questions, cen-
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Algorithm 1 Two-genome comparison by Cai et al. [4].
Input: Two genome annotation tables (A, B) mapping each gene to its GO terms.
Output: List of GO terms and their q-values.
1: for each GO term i in the ontology do
2: X[i]← 0
3: x[i]← 0
4: NA ← number of genes in genome A
5: for each gene of the genome A do
6: for each GO term annotated to the gene do
7: Search all ancestral GO terms in the DAG and add them to the annotation
8: Union of gene’s GO terms, including ancestral ones
9: for each GO term i do
10: xA[i]← xA[i] + 1
11: NB ← number of genes in genome B
12: for each gene of the genome B do
13: for each GO term annotated to the gene do
14: Search all ancestral GO terms in the DAG and add them to the annotation
15: Union of gene’s GO terms, including ancestral ones
16: for each GO term i do
17: xB[i]← xB[i] + 1
18: for each GO term do
19: Perform chi-square test with xA, xB, NA and NB as parameters
20: Perform FDR correction
tered around evolutionary characters, and is the main contribution of the work for genomic
inference.
The second difference is the use of KEGG ORTHOLOGY ontology (KO) to describe
the biological mechanisms present in the genomes. Unlike Gene Ontology, KEGG OR-
THOLOGY doesn’t define an hierarchy among its terms. Instead, terms reference classi-
fications and metabolic pathways from KEGG PATHWAY, a separated database. Since
no KO term has another term as its ancestor, there’s no need to search for KO ancestors
terms (lines 7 and 14 of the two-genome comparison algorithm), shortening the analysis.
The third difference is the choice of using previously processed information, stored in a
local database and containing the parameters to use in future chi-square tests. This choice
was made to reduce the computational running time of the tool, but requires predefined
genome groups in the database, not allowing arbitrary choices of genomes in each group.
Essentially, the algorithm simplifies and hastens the analysis by preprocessing parts of
the two-genome comparison, rather than by finding more efficient operations. This is also
why KOMODO limits itself to monophyletic taxa: the species in a monophyletic taxon
are defined by an evolutionary character of biological interest, serving as a well studied
criterion to investigate how each character shapes their evolution. Therefore, they are a
natural target of research interest and justifiable for a preprocessing treatment.
The last difference was to focus on the presence of KO terms in a genome, rather than
on how many of its elements are annotated to that term. Biologically, it means studying
whether a KO term is present or not, regardless of the term’s frequency in the genome.
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Figure 3.1: Illustration of monophyletic taxa, defined as a set with an species and all its
descendants. They are demarcated by dashed lines, any other set in the figure with more
than one element isn’t considered monophyletic. Examples of existing monophyletic taxa
include Fungi, Escherichia, Mammalia and Insecta.
Algorithm 2 KOMODO
Input: A local database with information of each monophyletic taxon present in KEGG
(number of genomes and how many possess the KO terms).
Input: Choice of two taxa to be compared.
Output: List of KO terms and their q-values.
1: NA ← number of genomes in taxon A
2: NB ← number of genomes in taxon B
3: for each KO term do
4: xA ← number of genomes on taxon A with the KO term
5: xB ← number of genomes on taxon B with the KO term
6: Perform chi-square test with xA, xB, NA and NB as parameters
7: Perform FDR correction
This limits the possibility of analyzing cases of paralogy (when one genome is annotated to
the same KO more than once, it counts only one time). Computationally and statistically,
it hastens the tests due to the smaller magnitude of the parameters: while each genome
usually have around a hundred KO terms, it can have dozens of thousands genes, each
with multiple GO terms and their ancestors.
Regarding the last two differences, the main concern was the computational time ex-
pected for the analysis. Since the original method was extended to compare multiple
genomes, there was a concern that the algorithm would not scale without adaptation.
Because the intended contribution was to demonstrate, within the scope of biological sci-
ences, the viability of comparing genomic groups to study evolutionary characters through
biological mechanisms, the algorithmic efficiency wasn’t prioritized and was left as a future
work.
Chapter 4
KOMODO2
KOMODO2 is an R implementation of a general method for first-principle comparative
genomics, with the steps and output illustrated in Figure 4.1. It contains two main
analysis modes: enrichment analysis allows grouping genomes arbitrarily and searching
for ontology terms significantly enriched or depleted in one group compared to another.
Correlation analysis allows ordering genomes according to a criterion and searches for
ontology terms correlated with this ordering. It doesn’t place restrictions on the analysis,
nor limits the ontology to either GO or KO, and expands the range of statistical tools
available for the search of significant differences between two groups of genomes. Ad-
ditionally, it addresses practical performance issues, improving reuse and manipulation
of the available information, being parallelized to handle genome-scale data in a feasible
time. It also expands the amount of information available to help scientists formulate new
hypothesis about the biological questions under analysis and offer reliability measures that
help evaluating these hypotheses.
One of the main concerns of the previous works was scalability. The original design for
functional comparison, seen in the previous algorithms, performs a complete analysis at
once, without reusing any previous information. Furthermore, when extending the method
to the comparison of groups, KOMODO applied restrictions to ensure that it would be
efficient for its immediate purpose, that is, the study of evolution among monophyletic
taxa.
The first contribution was to ensure that the method can have the desired generality
[3], as it was suggested that it could be extended to compare any arbitrary grouping of
genomes. Moreover, we expanded it to be able to work with different ontologies, within
the given information about them. We studied its ability to provide meaningful biological
information regarding the differences between the compared groups (Section 5).
The second contribution was to redefine its data structure and divide the procedure
into basic, independent operations that allows reusing previous information and clarify
its algorithmic steps. We provided an analysis of the time complexity and improved
its scalability, allowing it to have the generality originally intended. We extended it to
parallel procedures to provide additional scalability.
The third contribution was to expand the statistical tools and methods available to
interpret the results of the analysis, providing more ways to evaluate the biological phe-
nomenon in question. These tools also help minimizing bias and uncertainty of the result,
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Figure 4.1: Flowchart of KOMODO2’s structure. Green boxes are steps needed for the
result of an analysis or a visualization method, orange boxes are the statistical methods
adopted by an analysis and the blue box is an intermediate step. KOMODO2 receives
two groups of annotations (Test and Background) and an ontology of the user’s choice,
and stores information relative to term frequency in its data structure (Sections 4.1 and
4.2), used for the enrichment analysis, for the correlation analysis (Section 4.3), for the
genome bootstrapping (Section 4.4), for the hierarchical clustering (Section 4.6) and for
the histograms (Section 4.7).
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Figure 4.2: Data structure used for genome comparison. Each genome, from both the
test group (green boxes) and the background group (yellow boxes) have the number of
elements (ex: genes) annotated to a term counted and stored in a separated vector.
The sum of elements annotated to a term in all genomes of a group (T1, B1) are used
as parameters of the statistical tests. The total number of elements in each genome,
regardless of annotation, is stored for each group and are used when needed to obtain the
parameters (T0, B0).
giving an estimate of the likelihood that future changes in a group, such as additional
genomes or an updated annotation, will differ from results previously obtained.
4.1 Data Structures
The method’s structure is formalized as a set of genome vectors containing information
about how many elements (e.g. genes, proteins) are annotated in each genome for each
term, as well as the number of elements in each genome, as shown in Figure 4.2. When
applicable, it will include the ancestor terms as well. Each position of a genome vector
is standardized to a specific term of an ontology and contains the number of annotated
elements for the genome. These vectors are separated in two groups, test and background,
following the classification in the input data and forming a matrix for each group.
These genome vectors are used as parameters for the subsequent statistical tests.
Wilcoxon-Mann-Whitney and Kolmogorov-Smirnov tests retrieve the number of elements
annotated to a term by accessing the same position in each genome vector. Fisher’s
exact test’s parameters are the sum of all elements annotated to a term (T1 and B1), and
elements without that term (T0 and B0). These parameters are stored in four additional
vectors: T1, B1, T0 and B0, denominated parameter vectors. The total number of elements
in each group is also stored.
The genome vectors are independent of each other and can be manipulated separately.
This allows them to be processed in parallel and to be reused in a future analysis, without
the need to process them again due to a change in the groups, such as during bootstrap-
ping. Once processed, they evidence which terms of the ontology aren’t used, simplifying
the vectors and reducing the number of terms subjected to the statistical tests.
Informations regarding the parameter vectors can be updated alongside any change in
a term, with a list tracking which terms require remaking the KS and Wilcoxon-Mann-
Whitney tests. Alternatively, at the end, they can be updated by just summing all genome
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vectors in the respective group, calculating T0 and B0 by subtracting the total number
of elements by the vectors T1 and B1; this latter approach is favored when performing
these operations in parallel, avoiding the need for a semaphore to coordinate read/write
operations.
Algorithm 3 KOMODO2 - significance analysis
Input: Multiple genome annotations mapping each gene to its GO terms, divided in Test
and Background groups, to be added, removed, updated or moved.
Input: Command to add, remove, update or move each genome vector.
Input: (Optional) Genome vectors and parameter vectors from a previous analysis.
Output: List of terms and their q-values.
1: for each group do
2: for each genome do
3: if command to add genome then
4: AddGenome()
5: else if command to remove genome then
6: Remove genome vector
7: else if command to update genome then
8: UpdateGenome()
9: else if command to move genome then
10: Move genome vector to other group
11: Calculate parameter vectors
12: for each GO term do
13: Perform desired statistical test using the genome/parameter vectors
14: Perform FDR correction
4.2 Algorithm
The algorithm can be summarized as the execution of a list of operations (add, remove,
move, update), as shown in 3. The previous works are essentially a sequence of addition
operations, one for each genome and without any previous genome vectors available. The
complexity of Move and Remove are trivially shown to be O(u), where u is the number
of terms in the ontology, and can be easily implemented in O(1).
The overall complexity of the algorithm is O(nuh + uStest), where n is the number
of terms annotated in the input over all genomes to be processed, uh is the maximum
number of ancestor terms possible for a term of that ontology, u is the number of terms
in the ontology’s vocabulary and Stest is the complexity of the statistical test chosen (see
Section 2.2).
4.2.1 Find Ancestors
A frequent operation when using the Gene Ontology, or other ontologies organized as
DAGs, is the search for ancestor terms for each annotated element (ex: gene, protein),
which returns the original terms and their ancestors. It is part of the AddGenome()
operation and has the potential to be time consuming if not properly handled.
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The time complexity of a search for ancestor nodes of a term is O(uh), where uh is the
maximum number of ancestor terms possible for a term of the ontology. During retrieval,
it is reduced to constant time with a preprocessed inverted index structure, mapping each
term to all its ancestors. In the case of Gene Ontology, the list is already provided by
public available tools.
Algorithm 4 FindAncestors()
Input: Element’s annotation.
Output: Element’s annotation with ancestor terms included.
1: for each term annotated to the element do
2: Search all ancestral terms in the hierarchy and add them to the annotation
3: Remove duplicate terms
If using additional memory with a helper structure, such as a hash table, the duplicate
removal is done in O(kuh), where k is the number of terms annotated to the element
before including ancestors. After retrieving and finding unique terms, done with inverted
indexes, the final complexity of FindAncestors() is O(k + kuh) = O(kuh).
4.2.2 Add Genome
Adding a new genome vector is the basic operation in the previous algorithms, done
only twice in the two-genome comparison. The algorithm is show below (Algorithm 5).
It produces a genome vector with the count of how many elements of the genome are
annotated to each term, including ancestor terms. It consists in reading the annotation
of the a genome’s elements, expanding the annotation to its ancestor terms though the
FindAncestors() operation and counting how many elements are annotated to each term
of the ontology.
Algorithm 5 AddGenome()
Input: One genome annotation mapping each element to its terms.
Output: Genome vector X with count of elements NX created.
1: NX ← 0
2: for each term i in ontology do
3: X[i]← 0
4: for each element do
5: NX ← NX + 1
6: FindAncestors()
7: for each term i do
8: X[i]← X[i] + 1
Lines 2-3 are trivially shown to be θ(u). The second loop executes FindAncestors() for
each element of the genome, obtaining the ancestors of all terms in the annotation without
duplicate counts in any element. Since uh is the maximum number of ancestors for any
term, line 6 can be expressed as O(niuh), where ni is the number of terms annotated in
the genome. Lines 7-8 are O(niuh) as well.
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This is the most expensive operation, performed a total of g times, where g is the
number of genomes in the input, if no previous analysis is given to the algorithm. As
such, the complexity spent with AddGenome() is O(nuh), where n =
g∑
i
ni is the total
number of terms annotated in the genome.
4.2.3 Update Genome
Updating a genome vector is a basic operation for KOMODO2, not present in the previous
algorithms. The objective of the function is to update a genome vector without invok-
ing FindAncestors() as often as AddGenome(). It is meant to be used when a genome
annotation is updated with a few changes, building from the previous annotation.
Algorithm 6 UpdateGenome()
Input: New genome annotation A mapping each element to its terms.
Input: Previous genome annotation B mapping each element to its terms.
Input: Genome vector X with count of elements NX in the group.
Output: Genome vector X with count of elements NX updated.
1: Aonly ← A−B
2: Bonly ← B − A
3: CA∩B ← A− Aonly −Bonly
4: NX ← NX + size(Aonly)− size(Bonly)
5: for each element of Aonly do
6: FindAncestors()
7: for each term i do
8: X[i]← X[i] + 1
9: for each element of Bonly do
10: FindAncestors()
11: for each term i do
12: X[i]← X[i]− 1
13: for each element of CA∩B do
14: if terms of element in A 6= terms of element in B then
15: termsA ← FindAncestors() for element in A
16: termsB ← FindAncestors() for element in B
17: for each term i in termsA − termsB do
18: X[i]← X[i] + 1
19: for each term i in termsB − termsA do
20: X[i]← X[i]− 1
The input consists of two functional annotations of the same genome: the new ver-
sion (genome annotation A) and the one used previously (genome annotation B). The
UpdateGenome() uses the original annotation, comparing which elements were included,
removed or changed, and then expands them for ancestor terms.
The complexity of UpdateGenome() relative to AddGenome() is mostly determined
by the third loop (line 13). Since this loop executes FindAncestors() twice when the
two genome annotations differ, the number of changed elements should be lower than
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Figure 4.3: Correlation structure for x and y = {yi|i ∈ [1, u]}. The variables in y use
the genome vectors of both Test and Background groups to form a matrix, in which
each column is the ith term and the yi variable. The variable x is an arbitrary aspect
of the organisms, such as a chosen term (can be from a different ontology) or another
quantifiable aspect. The correlations are always between x and a yi, for a total of u
correlation coefficients calculated for x.
NA/2, where NA is the number of elements in genome A, to see any reduction in running
time. UpdateGenome() will see asymptotic gains in speed if the changes in elements
(sum of Aonly, Bonly and times when condition in line 14 is true), is limited to an order of
magnitude lower than NA. This allows for an update that can achieve a complexity lower
than the O(nguh) of AddGenome().
4.3 Correlation analysis
The correlation analysis, whose concept is explained in Section 2.4, evaluates how well a
specific variable x explains the variation of a second variable y. In KOMODO2’s case, the
variables refer to a quantifiable aspect of the organisms: the variable x is either a given
term in the analysis, or an arbitrary variable given separately by the user (e. g. G+C
content, number of cell types or life expectancy). The variable y = {yi|i ∈ [1, u]} consists
of all terms found among the genomes, with yi being the ith term to be correlated with
x.
Each variable is stored in a vector of size g = gT + gB, where g is the sum of the
number of genomes in the Test group (gT ) and the number of genomes in the Background
group (gB), and each vector position refers specifically to a distinct genome.
To produce y, KOMODO2 uses the genome vectors in a matrix structure, in which
each column yi refers to a term of the ontology. The variable x is correlated separately to
each yi, for a total of u correlation coefficients calculations.
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4.4 Bootstrap analysis
The bootstrap procedure is an optional step that estimates how robust the significance
results are, evaluating if an alternative dataset would result in different significant terms.
More specifically, each term receives an estimation by having multiple alternative datasets
generated and tested for significance. If a total of 950 out of 1000 alternative datasets
result in that term being significant, a 950/1000 score is reported.
To do that, the original dataset is sampled with replacement, producing a resample
with each group having as many genomes as the original. This is done with the indexes of
the existing genome vectors, requiring no additional space with new ones, nor additional
time with new AddGenome() operations. Each resampling is a sequence of genome indices,
stored in a vector of size g = gT + gB, where g is the sum of the number of genomes in
the Test group (gT ) and Background group (gB). The complexity of the bootstrap step
is O(buStest), where b is the number of resamplings, u is the number of terms in the
ontology’s vocabulary and Stest is the complexity of the statistical test (see Section 2.2).
The bootstrapping reuses the genome vectors when passing parameters to the statis-
tical tests and when processing the parameter vectors for the Fisher’s exact test. Each
resample is tested separately, a step that is embarrassingly parallel, and followed by a mul-
tiple comparison correction. KOMODO2 repeats it over each resample and keeps count
in how many each term was significant. This, divided by the total number of bootstraps,
is then reported as the bootstrap score (e. g. 95/100).
4.5 Ontology selection
The analysis isn’t restricted to a predefined ontology: KOMODO2 offers native support
for both Gene Ontology and KEGG Orthology as implemented in Bioconductor [28], and
can use a non-supported one, provided that a dictionary is given. It can be an existing
ontology, or one created by the user himself.
The dictionary used for an arbitrary ontology is a mapping of identifiers to their
description, meeting the definition for terms (see Section 2.1). In the absence of an
explicit dictionary, KOMODO2 can create one from the annotation data itself, keeping
track of used identifiers and leaving an empty description.
In the case of Gene Ontology, there are two additional lists of synonymous and obsolete
terms, which are used to remove and substitute terms in these categories for the most
current ones. This is a requirement to ensure that no term occurrence is unaccounted
due to lack of standardized annotation. Additionally, this prevents otherwise statistically
significant terms to be disregarded in the statistical tests.
4.6 Hierarchical clustering
Hierarchical clustering is a set of classification methods to find patterns in any multi-
dimensional dataset in which a distance measure is applicable. It offers a clustering of
the dataset based on the distance between each pair of its points. The default clustering
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method is the complete linkage, which merges clusters with the shortest distance between
their furthest pair of points and can run in O(n2) time, where n is the number of points
in the dataset.
The dataset can have the term frequency normalized by the total number of elements,
depending on the test. The Fisher’s exact test evaluates significance based on both
presences and absences of a term in each element and, because of that, the ratio of
elements with and without the term is of interest to interpret the results of the test.
Kolmogorov-Smirnov and Wilcoxon-Mann-Whitney tests, however, uses the raw term
frequency in each genome to study the distribution of term accumulation and are better
interpreted with non-normalized term frequency.
The hierarchical clustering finds groups with different patterns in the dataset. An
example is show in Figure 4.4. Green parts show a below average frequency for a given
term in a genome (negative Z-score, measure of standard deviations from the mean),
while red parts indicate above average frequency (positive Z-score), with sections with an
homogeneous color pattern between its columns or rows forming groups with relatively
similar behavior.
The method doesn’t attempt to find a specific number of clusters. Instead, it estab-
lishes which points of the dataset (rows), or dimensions (columns), are more similar to
each other. This leaves the interpretation of the groups open to the researcher, which may
prefer to cross the results with another information, such as phylogeny and phenotypes.
4.7 Histogram
KOMODO2 allows the visualization of each term’s distribution though histograms, giving
a quick insight of which patterns the term may present in the test and background groups.
This is illustrated in Figure 4.5, giving an example of a bimodal distribution for the
background group, with one of the nodes being above the number of occurrences of any
other organism in both groups.
The histograms show the number of occurrences of the term in each group as its
x axis, with the normalized number of organisms in the group (density) as the y axis.
The information is obtained directly from the genome vectors, with the normalization
performed to allow a fair comparison between groups with different number of organisms.
The motive for adding histograms is to help identifying the reasons a term is significant,
or not, in a statistical test. In the example of Figure 4.5, the rightmost node for the
background group can explain why this term would not be significant for the Fisher’s exact
test, as it comprises of either a group or outliers inflating the total number of occurrences
of that term. At the same time, this term may be significant for the Kolmogorov-Smirnov
test due to the distribution difference causing a huge difference between the empirical
distribution function (test group) and the cumulative distribution function (background
group).
Another reason is to identify cases when a term merits further investigation. The
interpretation of the pattern may raise hypotheses about possible subgroups or biolog-
ical phenomena occurring in the dataset, which may be as interesting as the original
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Figure 4.4: A heatmap example, which illustrates the results of a hierarchical cluster-
ing. Each row represents a point of the dataset, while each column is a dimension of
that point. In this example, each row/point represents an arbitrary lineage, while each
column/dimension is the frequency of a GO term in that lineage. Green sections in-
dicates low normalized values (negative Z-score) for a specific dimension/column of a
certain point/row, red sections indicate high values (positive Z-score) and black sections
have values within average (less than 1 standard deviation). The red/blue bar indicates
from which group each lineage came: red for the test group, blue for the background
group. The dendrograms above and on the left of the heatmap shows how each point was
clustered and the similarity between dimensions.
CHAPTER 4. KOMODO2 38
Figure 4.5: A histogram example, which illustrates the distribution of a term (in this case,
GO:1901265) over the genomes in both the test group (blue area) and the background
group (red area). The number of occurrences of a term is the x axis, and its density
(normalized number of organisms of the group with that number of occurrences) is the y
axis.
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phenomenon investigated.
4.8 Parallelization
Some of the steps in KOMODO2 may run in parallel, which reduces the algorithm’s
running time if given enough processors. The first parallelized step is the processing of
the list of commands for each genome, as each genome vector can be processed sepa-
rately. Given enough processors, this can reduce the asymptotic complexity of O(nuh) to
O(nguh), where n is the number of terms annotated in the input over all genomes to be
processed, ng is the number of terms annotated to a single genome, uh is the maximum
number of ancestor terms possible for a term of that ontology and n > ng. The parameter
vectors (T1, T0, B1 and B0) are calculated after all genome vectors are finished, rather
than whenever one is completed, to avoid need for control over a shared variable.
Two other larger parallelized steps are the statistical tests and the bootstrap analysis.
The first is executed for multiple terms, each test being independent of the others. The
second performs these tests a number of times, all of which are also independent of each
other. Parallelization of these steps allow the O(buStest) component (with bootstrap) to
be reduced to O(Stest) instead.
For practical implementations, the overhead of managing the parallelized tasks isn’t
negligible and can reduce, or even surpass, the gains from parallel processing if the tasks
are small [29, 30]. Parallelizing steps that are small by themselves, like FindAncestors(), in
each genome has little impact in the overall performance due to the time spent scheduling
the task and serializing the result. To minimize how often this overhead is incurred, the
tasks are divided in chunks for each processor and the parallelization focus on the larger
levels of abstraction (e.g. bootstrap) whenever possible.
Chapter 5
Case study: pathogenicity in
Escherichia coli
To evaluate KOMODO2, we performed three experiments involving two groups of Es-
cherichia coli : one group composed of genomes of pathogenic lineages and one with
free-living lineages. We searched for important pathogenicity mechanisms that determine
the ability of the first group to cause disease.
The experiments compare the genome annotation of 33 lineages of pathogenic Es-
cherichia coli and 17 free-living lineages, including their identified plasmids (i.e. non-
chromosomal DNA); their accession number (identifier) and evolutionary relationship are
shown in Tables A.1 and A.2, and in Figure 5.1. The objective is to compare significant
terms among the pathogens with the known pathogenic factors in the scientific literature.
The Escherichia coli is a model organism, a bacteria commonly found in the intestinal
tract of endotherm organisms, normally a free-living organism with a symbiotic rela-
tionship. Many strains (or lineages) were identified, some of which are pathogenic and
responsible for a broad range of diseases. They are classified around pathotypes, which
define lineages that cause a common disease profile and share similar virulence factors
[34]. Of particular interest in the following experiments are the EHEC (Enterohemor-
rhagic Escherichia coli) and EPEC (Enteropathogenic Escherichia coli) pathotypes, with
more severe symptoms and a high number of virulence-related genes specific to them [35].
The species was chosen because it is a model organism and the most well studied
cellular life-form to date, with a vast literature about its molecular mechanisms and,
therefore, one of the best models to use for evaluation. Many studies are dedicated to
the mechanisms that confer pathogenicity to some of its lineages [36, 37], that make them
particularly virulent [38, 39] and how lineages that affect other species can evolve to
infect humans [40]. KOMODO2’s analysis with this species can be compared with the
scientific literature to evaluate conformance to known information, possible inferences,
differences detected by its tools and supported ontologies and how KOMODO2 supports
the formulation of hypotheses about the biological question.
The annotation of the E. coli proteomes was obtained from Uniprot [41] as of May
2014, with the genomes grouped by the capability for pathogenicity after human cura-
tion. Other potential lineages, whose pathogenicity was ambiguous or uncertain, weren’t
included to reduce possible noise in the data. The annotation also includes proteins
40
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Figure 5.1: Phylogenetic tree of E. coli lineages studied in this experiment. Those in red
with an asterisk are free-living lineages. Numbers in blue are bootstrap confidence levels
(out of 100 executions) for each clade of the tree. This phylogenetic tree was generated
by obtaining a supersequence for each species from their filtered coding DNA sequences.
For this purpose, we initially used the ORTHOMCL 1.4 [31] to classify protein data to
homologs groups. Those groups were filtered using quality and phylogenetic criteria to
analyze only 1-1 orthologs present in all genomes with no gene fragments, as implemented
in the POTION software (version 1.0.2) [32]. We further analyzed those 1-1 ortholog
groups by performing multiple sequence alignment using MUSCLE [33] and concatenating
individual sequences within each genome to create the supersequence. We proceeded by
generating the consensus phylogenetic tree using proml software from the Phylip package
[24] with 100 bootstrap executions.
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translated from plasmids found in the lineage. This addition is important when study-
ing pathogenic bacteria due to the presence of pathogenicity genes in some plasmids.
Additional information can be found in [42].
The first experiment compares the functional annotation between the genomes of the
two groups in search for both known and new pathogenicity mechanisms. The second ex-
periment is inspired by the results of the first and searches for differences in pathogenicity
mechanisms between EHEC/EPEC lineages against other pathotypes. The third exper-
iment analyses whether pathogenic E. coli lineages are prone to have more plasmids in
their genome than free-living ones.
5.1 First experiment: pathogenicity mechanisms in E.
coli
This experiment uses the proteome annotation data to search for which mechanisms are
used by pathogenic E. coli strains and evaluate KOMODO2’s capability to identify known
mechanisms in the scientific literature. The annotation of the proteins coming from both
the chromosome and the plasmids are merged for each organism, not distinguishing which
part of its DNA encodes that protein.
5.1.1 Significance analysis
The experiment included the Fisher’s Exact test, the Kolmogorov-Smirnov test and the
Wilcoxon-Mann-Whitney test for both GO and KO annotation. The raw results can be
seen in the Appendix A.2. For GO terms, Fisher’s test was able to detect 25 overrepre-
sented terms, less than the 145 found by KS test and the 125 found by Wilcoxon test. A
total of 12 terms (1 KO term) were commonly identified by all three tests (table 5.1).
ID Term
GO:0009405 pathogenesis
GO:0019028 viral capsid
GO:0019012 virion
GO:0044423 virion part
GO:0015074 DNA integration
GO:0008821 crossover junction endodeoxyribonuclease activity
GO:0016889 endodeoxyribonuclease activity, producing 3’-phosphomonoesters
GO:0016894 endonuclease activity, active with either ribo- or deoxyribonucleic acids
and producing 3’-phosphomonoesters
GO:0009617 response to bacterium
GO:0006310 DNA recombination
GO:0042742 defense response to bacterium
K01160 rusA; crossover junction endodeoxyribonuclease RusA [EC:3.1.22.4]
Table 5.1: Significant terms present in the three statistical
tests (qvalue < 0.05).
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Figure 5.2: Venn diagram of significant results for the three statistical tests. A) Number
of significantly overrepresented GO terms, only 11 terms are significant in the three tests,
with a considerable overlap between the KS and the Wilcoxon test. B) Number of signif-
icantly overrepresented KO terms, 1 term is significant in the three tests, with only the
Wilcoxon test having enough sensibility to detect more than a few significant terms.
Among the terms found in common, ”pathogenesis” (GO:0009405) works as a valida-
tion that the analysis is evaluating the desired difference between both groups. This term
was also the one with the lowest qvalue in the Fisher’s exact test (qvalue = 9.01e-18)
and tied for the lowest qvalue in Kolmogorov-Smirnov (qvalue = 2.70e-03) and Wilcoxon-
Mann-Whitney (qvalue = 4.23e-04) tests. The other terms can be grouped as virion par-
ticles (GO:0019028, GO:0019012 and GO:0044423), DNA integration and related mech-
anisms (GO:0015074, GO:0008821, GO:0016889, GO:0016894, GO:0006310 and K01160)
and defensive response to bacteria (GO:0009617 and GO:0042742).
One mechanism known to be important to E. coli pathogenicity is protein ubiquitina-
tion (Table 5.2), was found to be overrepresented in our experiment. Its terms received
some of the smallest qvalues of the analysis and a 100/100 bootstrap score (qvalue < 0.05)
in the Fisher’s exact test, but aren’t significant in the other two statistical tests. Another
overrepresented mechanism is related to DNA metabolism (Table 5.3), specifically the
ability to alter the genomic content of the cell, all being significant in the three statistical
tests (see Table 5.1), most having a bootstrap score (qvalue < 0.05) above 90/100.
A third mechanism is the protein secretion method adopted by pathogen E. coli (Table
5.5). It is described by types based on the exact mechanism, with the KO terms related
to the types III and VI being significant in the Wilcoxon-Mann-Whitney test. Some KO
terms related to secretion were significant in the Wilcoxon test, but not in Fisher’s test
(K11911, K03222, K11892, K11907, K03227).
The fourth result is the conversion of urea into ammonia, a reverse process from the
conversion performed by the liver of many land animals. The bootstrap indicates that
pathogenic strains consistently have urea metabolism overrepresented, but not as high
for the urease process (catabolic process) itself. These terms were not significant in the
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ID qvalue Bootstrap Definition
GO:0004842 1.88e-16 100/100 ubiquitin-protein transferase activity
GO:0016567 4.10e-14 100/100 protein ubiquitination
GO:0032446 4.10e-14 100/100 protein modification by small protein conju-
gation
GO:0070647 1.83e-11 100/100 protein modification by small protein conju-
gation or removal
Table 5.2: Terms related to ubiquitination in pathogenic
E. coli (Fisher’s exact test, bootstrap for qvalue < 0.05).
ID qvalue Bootstrap Definition
K01160 3.36e-07 100/100 rusA; crossover junction endodeoxyribonu-
clease RusA [EC:3.1.22.4]
GO:0015074 5.88e-07 97/100 DNA integration
GO:0008821 3.13e-04 96/100 crossover junction endodeoxyribonuclease
activity
GO:0016889 3.13e-04 96/100 endodeoxyribonuclease activity, producing
3’-phosphomonoesters
GO:0016894 1.39e-02 70/100 endonuclease activity, active with either ribo-
or deoxyribonucleic acids and producing 3’-
phosphomonoesters
GO:0006310 1.45e-02 64/100 DNA recombination
Table 5.3: Terms related to DNA metabolism in
pathogenic E. coli (Fisher’s exact test, bootstrap for
qvalue < 0.05).
Kolmogorov-Smirnov and Wilcoxon-Mann-Whitney tests and had a low bootstrap value
(0/100 in KS test, 15/100 in Wilcoxon-Mann-Whitney, bootstrap for qvalue < 0.05).
A fifth result is the presence of virion parts, or viral proteins (Table 5.6). Similar to the
protein ubiquitination, these terms had some of the lowest qvalues and highest bootstrap
values in the Fisher’s exact test. Unlike them, though, virion terms were also significant
in the Kolmogorov-Smirnov and the Wilcoxon-Mann-Whitney tests, also having a high
bootstrap score in these tests (95/100 for KS test, 98/100 to 99/100 for Wilcoxon test,
qvalue < 0.05).
The sixth finding was the presence of terms related to iron acquisition, which includes
proteins like hemoglobin, lactoferrin, siderophores and yersiniabactin. These terms were
found significant in the Wilcoxon-Mann-Whitney test, with few being overrepresented
in the Fisher’s exact test and in the KS test. The GO terms for iron transport and
siderophore (compound with high affinity for iron cations) had a bootstrap score of at
least 79/100, while most of the KO terms had a bootstrap score below 70/100, for qvalue
< 0.05.
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ID qvalue Bootstrap Definition
GO:0019627 6.55e-04 91/100 urea metabolic process
GO:0043419 1.25e-02 76/100 urea catabolic process
GO:0009039 1.25e-02 76/100 urease activity
Table 5.4: Terms related to urea metabolism in pathogen
E. coli. Fisher’s exact test, bootstrap for qvalue < 0.05.
ID qvalue Bootstrap Term
GO:0050708 1.72e-03 92/100 regulation of protein secretion
GO:0051046 1.72e-03 92/100 regulation of secretion
K11911 3.11e-02 75/100 vasL; type VI secretion system protein VasL
K03222 4.16e-02 69/100 yscJ, sctJ, hrcJ; type III secretion protein J
K11892 4.38e-02 63/100 impK, ompA, vasF, dotU; type VI secretion
system protein ImpK
K11907 4.38e-02 63/100 vasG, clpV; type VI secretion system protein
VasG
K03227 4.83e-02 61/100 yscS, sctS, hrcS; type III secretion protein S
Table 5.5: Terms related to protein secretion in
pathogenic E. coli lineages. GO terms identified in
Fisher’s exact test, KO terms identified in Wilcoxon-
Mann-Whitney test, bootstrap for qvalue < 0.05.
ID qvalue Bootstrap Definition
GO:0019028 4.59e-08 99/100 viral capsid
GO:0019012 9.74e-08 99/100 virion
GO:0044423 9.74e-08 99/100 virion part
Table 5.6: Terms related to virion in pathogen E. coli.
Fisher’s exact test, bootstrap for qvalue < 0.05.
ID qvalue Bootstrap Definition
GO:0006826 6.03e-03 95/100 iron ion transport
GO:0034755 7.27e-03 94/100 iron ion transmembrane transport
GO:0030001 7.27e-03 95/100 metal ion transport
GO:0015891 1.82e-02 83/100 siderophore transport
GO:0098660 1.93e-02 77/100 inorganic ion transmembrane transport
GO:0000041 2.11e-02 79/100 transition metal ion transport
GO:0015343 2.11e-02 79/100 siderophore transmembrane transporter ac-
tivity
GO:0042927 2.11e-02 79/100 siderophore transporter activity
Continued on the next page...
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Table 5.7 – Terms related to iron acquisition in pathogen E. coli.
ID qvalue Bootstrap Definition
GO:0098655 2.15e-02 73/100 cation transmembrane transport
GO:0098662 2.15e-02 73/100 inorganic cation transmembrane transport
K02014 2.87e-02 71/100 TC.FEV.OM; iron complex outermembrane
recepter protein
GO:0043167 3.71e-02 66/100 ion binding
K16087 3.72e-02 73/100 TC.FEV.OM3, tbpA, hemR, lbpA, hpuB,
bhuR, hugA, hmbR; hemoglobin/transfer-
rin/lactoferrin receptor protein
K02013 4.16e-02 67/100 ABC.FEV.A; iron complex transport system
ATP-binding protein [EC:3.6.3.34]
K04783 4.16e-02 62/100 irp5, ybtE; yersiniabactin salicyl-AMP ligase
[EC:6.3.2.-]
K04784 4.16e-02 62/100 irp2, HMWP2; yersiniabactin nonribosomal
peptide synthetase
K04785 4.16e-02 62/100 irp3, ybtU; yersiniabactin synthetase, thia-
zolinyl reductase component
K15721 4.16e-02 62/100 fyuA; pesticin/yersiniabactin receptor
K04786 4.16e-02 62/100 irp1, HMWP1; yersiniabactin nonribosomal
peptide/polyketide synthase
K07225 4.16e-02 66/100 hmuS; putative hemin transport protein
K07243 4.38e-02 65/100 FTR, efeU; high-affinity iron transporter
K16089 4.83e-02 57/100 TC.FEV.OM2, fepA, iroN, cirA, pfeA, cfrA,
hmuR; outer membrane receptor for ferrien-
terochelin and colicins
K02016 4.83e-02 60/100 ABC.FEV.S; iron complex transport system
substrate-binding protein
Table 5.7: Terms related to iron acquisition in pathogen
E. coli, Wilcoxon-Mann-Whitney test, bootstrap for
qvalue < 0.05.
In terms of underrepresentation (qvalue < 0.05), 1465 GO terms were obtained by
the Fisher’s exact test (data not shown), covering basic metabolic processes for survival,
growth and maintenance of the cell structure. The KS and Wilcoxon-Mann-Whitney
tests did not detect any GO term as underrepresented. Among the KO terms, three
terms were found underrepresented by the Wilcoxon test (K06153 ”bacA; undecaprenyl-
diphosphatase”, K01854 ”glf; UDP-galactopyranose mutase” and K03277 ”waaU, rfaK;
heptosyltransferase IV”), with no KO terms found by the other tests.
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5.1.2 Correlation analysis
To further investigate pathogenicity mechanisms in E. coli, we performed a correlation
analysis to find KO and GO terms that follow a pattern with the variation of raw counts
of pathogenesis (GO:0009405) GO term across all genomes evaluated in this case study.
Among the Pearson Correlation Coefficients found, 57 terms were above 0.8, seen in Table
5.8.
The correlation analysis detected a high correlation between pathogenesis and the
type III secretion system described previously. This includes proteins needed for the
type III system (K03221, K03222, K03227, K03219, K03230, K03220, K03224), regula-
tion of secretion (GO:0051046, GO:0050708) and localization (GO:0060341, GO:0032880,
GO:0070201). Related terms include protein transportation (GO:0051223) and receptors
(K12784, K12790, K12789) [43].
The analysis also show high correlation between pathogenesis and protein ubiquiti-
nation (GO:0004842, GO:0016567, GO:0032446, GO:0070647), as well as between patho-
genesis and urease activity (GO:0019627, GO:0043419, GO:0009039, K01428, K01429,
K01430, K03187, K03188, K03189).
Highly correlated terms that weren’t found to be significant in the first experiment
include effectors, both LEE-encoded (K12788, K12785, K12786, K12787) and non-LEE-
encoded ones (K16042, K16041), as well as shiga toxin (K11006, K11007). Among the
significant terms, those related to virions, iron ion transport and DNA integration/recom-
bination were not found to be correlated with pathogenesis, showing a coefficient below
0.8.
Term PCC Description
K12788 0.924 espH; LEE-encoded effector EspH
K03224 0.923 yscN, sctN, hrcN; ATP synthase in type III secretion protein N
[EC:3.6.3.14]
K03220 0.921 yscD, sctD; type III secretion protein D
K12785 0.921 espG, virA; LEE-encoded effector EspG
K12786 0.921 espF; LEE-encoded effector EspF
K12787 0.921 map; LEE-encoded effector Map
GO:0050708 0.915 regulation of protein secretion
GO:0051046 0.915 regulation of secretion
GO:0060341 0.902 regulation of cellular localization
GO:0004842 0.897 ubiquitin-protein transferase activity
K03219 0.892 yscC, sctC; type III secretion protein C
K03230 0.892 yscV, sctV, hrcV; type III secretion protein V
GO:0016567 0.891 protein ubiquitination
GO:0032446 0.891 protein modification by small protein conjugation
GO:0072519 0.891 parasitism
GO:0070647 0.889 protein modification by small protein conjugation or removal
GO:0072593 0.888 reactive oxygen species metabolic process
K16042 0.886 nleH; non-LEE-encoded effector NleH
K09953 0.884 lpxR; lipid A 3-O-deacylase
K12784 0.884 tir; translocated intimin receptor
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Table 5.8 – Correlation of GO:0009405 ”pathogenesis” with other terms in E. coli.
Term PCC Description
K12790 0.884 eae; intimin
K16041 0.884 nleA; non-LEE-encoded effector NleA
K12789 0.878 tccP; Tir-cytoskeleton coupling protein
K13743 0.870 ipgB2; protein IpgB2
GO:0032880 0.865 regulation of protein localization
GO:0051223 0.865 regulation of protein transport
GO:0070201 0.865 regulation of establishment of protein localization
K10938 0.861 acfC; accessory colonization factor AcfC
GO:0004197 0.855 cysteine-type endopeptidase activity
K03221 0.852 yscF, sctF; type III secretion protein F
K03227 0.850 yscS, sctS, hrcS; type III secretion protein S
K03222 0.849 yscJ, sctJ, hrcJ; type III secretion protein J
K07804 0.848 pagC; putatice virulence related protein PagC
GO:0006801 0.838 superoxide metabolic process
GO:0004784 0.838 superoxide dismutase activity
GO:0016721 0.838 oxidoreductase activity, acting on superoxide radicals as acceptor
K04565 0.838 SOD1; superoxide dismutase, Cu-Zn family [EC:1.15.1.1]
K07484 0.823 K07484; transposase
GO:0019836 0.821 hemolysis by symbiont of host erythrocytes
GO:0052331 0.821 hemolysis in other organism involved in symbiotic interaction
GO:0030597 0.821 RNA glycosylase activity
GO:0030598 0.821 rRNA N-glycosylase activity
K11006 0.821 stxA; shiga toxin subunit A
K11007 0.821 stxB; shiga toxin subunit B
K03226 0.814 yscR, sctR, hrcR; type III secretion protein R
GO:0019627 0.813 urea metabolic process
GO:0043419 0.813 urea catabolic process
GO:0009039 0.813 urease activity
GO:0018307 0.813 enzyme active site formation
K01428 0.813 ureC; urease subunit alpha [EC:3.5.1.5]
K01429 0.813 ureB; urease subunit beta [EC:3.5.1.5]
K01430 0.813 ureA; urease subunit gamma [EC:3.5.1.5]
K03187 0.813 ureE; urease accessory protein
K03188 0.813 ureF; urease accessory protein
K03189 0.813 ureG; urease accessory protein
K00901 0.813 dgkA, DGK; diacylglycerol kinase (ATP) [EC:2.7.1.107]
K07497 0.806 K07497; putative transposase
Table 5.8: Correlation of term ”pathogenesis” (GO:0009405)
with other terms in GO and KO, for R > 0.8.
5.1.3 Hierarchical clustering and distributions
KOMODO2 also performs an automatic hierarchical clustering for each statistical test,
in order to allow scientists to seek clusters among significant terms and organisms to find
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biologically insightful patterns and possible bias, as explained in Section 4.6.
In the heatmap for the Fisher’s exact test results (Figure 5.3), a notable pattern is the
subgroup of ten pathogenic lineages with high frequency of most of the significant terms,
as indicated in dashed lines. Moreover, terms related to urease activity, protein secretion
and protein ubiquitination are almost exclusively overrepresented in this group. These
are either EHEC or EPEC lineages, two pathotypes known for high virulence relative to
other E. coli strains.
The main pattern for the remaining pathogenic lineages, when compared with free-
living lineages, is the higher frequency of terms related to DNA recombination, DNA
integration, virion or endodeoxyribonuclease activity. Most of the other significant GO
terms weren’t necessarily observed in high amounts in pathogenic lineages outside the
EHEC/EPEC subgroup. This pattern isn’t present in the heatmap of the KS and
Wilcoxon-Mann-Whitney tests, which shows more homogeneous test (pathogenic lin-
eages) and background (free-living lineages) groups (Appendix A.3). In the heatmap,
it was also possible to observe ontology terms that group together. Of special interest
was the clustering of virion-related terms with pathogenesis, suggesting a link between
the two phenomena.
KOMODO2 also generates a histogram of occurrences relative to the number of organ-
isms generated for each significant term, describing its normalized distribution as seen in
Figure 5.4. The patterns seen for DNA integration, virion and iron ion transport were the
main result seen in the KS and Wilcoxon-Mann-Whitney tests, with an occasional outlier
for the background group with higher occurrences than any of the test group. Meanwhile,
the patterns seen in protein ubiquitination, protein secretion and urease activity were ab-
sent in the significant terms found by KS and Wilcoxon-Mann-Whitney tests, but present
in 41% of the significant terms from the Fisher’s exact test (10 out of 24 terms).
5.2 Second experiment: EHEC/EPEC pathotype anal-
ysis
We found a grouping pattern on our heatmap (Figure 5.3) that comprises virtually all
EHEC/EPEC genomes analyzed in our study (exception being O127:H6 strain E2348/69),
suggesting this subgroup forms a biologically coherent group for the study of pathogenic-
ity in E. coli. Additionally, an article by Ogura et al [35] provides an additional support
for the results of our previous experiment, stating that these two pathotypes possesses an
extra chromosomal part containing many EHEC/EPEC-specific virulence genes marked
by the presence of mobile/integrative elements. This supports the validity of the exper-
iment’s results and the merit of analyzing the EHEC/EPEC subgroup, as their higher
virulence is likely related to mechanisms supported by their additional genes.
These two pathotypes are of particular importance for their high virulence and their
convergent emergence from lineages of different evolutionary histories [35], as observed
in the phylogenetic tree (Figure 5.1) and in the hierarchical clustering (Figure 5.3) of
the previous experiment, summarized in Figure 5.5. The mentioned article by Ogura et
al also investigated the evolution of the EHEC lineages. They compared the evolution
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Figure 5.3: Heatmap for significant GO terms (qvaule < 0.05), showing a pattern involving
EHEC/EPEC lineages (group in dashed lines), as well as patterns in DNA recombina-
tion/integration and virion-related terms. Green parts indicate low normalized frequency
of a term (below 2 standard deviations), red indicates high normalized frequency (above
2 standard deviations). The blue/red bar on the left indicates whether the lineage is
pathogenic (blue, test group) or free-living (red, background group).
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Figure 5.4: Histograms of significant terms, for the six patterns described in 5.1.1. The
X axis describes occurrences of the term, the Y axis describe the density (normalized fre-
quency of organisms) in the test group (pathogenic strains, in blue) and in the background
group (free-living strains, in red).
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Figure 5.5: Comparison of phylogenetic tree and hierarchical clustering for the ten
EHEC/EPEC lineages with high representation for the majority of the overrepresented
GO terms (Fisher’s exact test, qvalue < 0.05). (A) Parts of the phylogenetic tree with
the ten lineages, indicated by the dashed rectangles, over the evolutionary history of
the E. coli. Groups of lineages from other pathotypes and free-living ones separate
these ten strains, indicating independent emergence of the EHEC/EPEC phenotype. (B)
Fragment of the hierarchical clustering from the previous experiment, grouping the ten
EHEC/EPEC lineages in a single cluster. This indicates a convergent molecular structure,
despite the evolutionary separation seen in the phylogenetic tree.
of the O157:H7 strains, the most studied and prevalent lineages of the pathotype at
the time of their publication, with other EHEC lineages (O26, O103 and O111), and
with other 21 E. coli/Shigella strains for a phylogenetic analysis. Their results include
an abnormal presence of integrative elements, EHEC/EPEC-specific genes and urease
activity, and supports the hypothesis that the EHEC pathotype can emerge in different
evolutionary branches of E. coli through mobile genetic elements [35], which was also
supported by KOMODO2 when comparing the phylogenetic tree with the heatmap from
the first experiment.
This experiment compares the ten EHEC/EPEC strains clustering in the heatmap of
Figure 5.3, who form a distinct pattern of high representation for those GO terms, with
the other pathogenic lineages. The goal is to evaluate KOMODO2’s ability to further
detail the findings in the scientific literature about E. coli pathogenicity though the study
of the specific mechanisms of the EHEC/EPEC pathotypes.
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Figure 5.6: Venn diagram of significant results for the three statistical tests, for both GO
terms and KO terms at significance level qvalue < 0.05 and qvalue < 0.01. In this analysis,
the KS test was unable to find any overrepresented term not found by the Wilcoxon test.
5.2.1 Significance analysis
This experiment compares the ten EHEC/EPEC strains clustering in the heatmap of
Figure 5.3, who form a distinct pattern of high representation for those GO terms when
compared with the other pathogenic lineages.
As in the first experiment, we included the Fisher’s Exact test, the Kolmogorov-
Smirnov test and the Wilcoxon-Mann-Whitney test for both GO and KO annotation. In
this order, at a significance level of qvalue < 0.05, we found 95, 158 and 329 significant GO
terms and 46, 38 and 112 significant KO terms for these tests. At a significance level of
qvalue < 0.01, we found 79, 69 and 194 significant GO terms and 28, 17 and 74 significant
KO terms. We’ll focus on those significant at qvalue < 0.01 in this experiment to better
control the expected number of false positives, and all bootstrap scores are reported for
qvalue < 0.01, unless stated otherwise.
In this analysis, the KS test was unable to find any term not also found by the
Wilcoxon-Mann-Whitney test (see Figure 5.6). The Wilcoxon test was able to identify
more exclusive terms (i. e. not found by other tests) than the Fisher’s test, especially for
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KO terms. Among the exclusive KO terms, the Fisher’s exact test identified terms related
to transposase (K07497, K07484, K07483), while the Wilcoxon test identified a wide range
of mechanisms, including iron ion transport (K02010, K02011, K02012), urease-related
proteins (K01428, K01429, K01430) and type III secretion proteins (K03221, K03227,
K03222, K03226, among others).
The exclusive significant GO terms for Fisher’s test include xenobiotic metabolism
processes (GO:0006805, GO:0009410, GO:0042178, GO:0071466) and entry into the host
through fusion of a virus membrane (GO:0044409, GO:0046718, GO:0030260, GO:0051806,
GO:0051828, GO:0039663, GO:0061025, GO:0019064, GO:0039663, GO:0044800, GO:004
4803). Exclusive significant GO terms for the Wilcoxon test includes ATP biosyntetic pro-
cess (GO:0006754, GO:0046034, GO:0006743, GO:0006744), ATPase activity (GO:00447
69, GO:0036442, GO:0046961), quinone biosynthesis (GO:1901663, GO:1901661), single-
species biofilm formation (GO:0044010), hemolysis in another organism (GO:0044179,
GO:0044364, GO:0031640, GO:0001906, GO:0051715, GO:0035821), protein secretion by
the type III secretion system (GO:0030254) and catalase activity (GO:0004096, GO:00427
44, GO:0042743), among many others.
The KO terms found by all the three statistical tests match the results from the
article by Ogura et al, which reported an abundance of effectors related to the type III
secretion system (intimin receptor and both LEE and non-LEE-encoded effectors) and
prophage (K14744, K12789). LEE and non-LEE-encoded effector terms were found to be
nearly inexistent in the background group, often having only one occurrence among the
23 lineages, while having at least 10 occurrences in the test group. Related GO terms
include regulation of secretion, cellular localization and protein ubiquitination, which are
expected to be annotated to proteins from the type III secretion system and secreted
effectors.
ID Term
GO:0004842 ubiquitin-protein transferase activity
GO:0019787 ubiquitin-like protein transferase activity
GO:0016567 protein ubiquitination
GO:0032446 protein modification by small protein conjugation
GO:0070647 protein modification by small protein conjugation or removal
GO:0072519 parasitism
GO:0051704 multi-organism process
GO:0009405 pathogenesis
GO:0044403 symbiosis, encompassing mutualism through parasitism
GO:0044419 interspecies interaction between organisms
GO:0032880 regulation of protein localization
GO:0050708 regulation of protein secretion
GO:0051046 regulation of secretion
GO:0051223 regulation of protein transport
GO:0060341 regulation of cellular localization
GO:0070201 regulation of establishment of protein localization
GO:1903530 regulation of secretion by cell
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Table 5.9 – Significant terms present in the three statistical tests.
ID Term
GO:0008234 cysteine-type peptidase activity
GO:0004197 cysteine-type endopeptidase activity
GO:0019835 cytolysis
GO:0098542 defense response to other organism
GO:0042742 defense response to bacterium
GO:0009617 response to bacterium
GO:0051707 response to other organism
GO:0043207 response to external biotic stimulus
GO:0009607 response to biotic stimulus
GO:0003796 lysozyme activity
K13743 ipgB2; protein IpgB2
K14744 rzpD; prophage endopeptidase [EC:3.4.-.-]
K16042 nleH; non-LEE-encoded effector NleH
K12789 tccP; Tir-cytoskeleton coupling protein
K01185 E3.2.1.17; lysozyme [EC:3.2.1.17]
K10938 acfC; accessory colonization factor AcfC
K03220 yscD, sctD; type III secretion protein D
K12785 espG, virA; LEE-encoded effector EspG
K12786 espF; LEE-encoded effector EspF
K12787 map; LEE-encoded effector Map
K09953 lpxR; lipid A 3-O-deacylase
K12784 tir; translocated intimin receptor
K12788 espH; LEE-encoded effector EspH
K12790 eae; intimin
K16041 nleA; non-LEE-encoded effector NleA
Table 5.9: Significant terms present in the three statisti-
cal tests (qvalue < 0.01).
Protein ubiquitination (GO:0016567), one of the results in the first experiment, is
overrepresented in all the three tests, possessing a 100/100 bootstrap score for its terms,
in contrast to its overrepresentation for the Fisher’s test only in the previous experiment.
Meanwhile, DNA integration/recombination is not significant in any of the three tests,
having a bootstrap score below 10/100 in all cases.
Regulation of protein secretion was significant in all the three tests, having a 100/100
bootstrap score for most related terms (GO:0032880, GO:0050708, GO:0051046, GO:0051
223, GO:0060341, GO:0070201, GO:1903530). The term GO:0009306 ”protein secretion”
itself isn’t significant for the KS test under a significance value of qvalue < 0.01, (qvalue
= 0.0143), but is significant for the other two tests. The bootstrap score (qvalue < 0.01)
for this term was 76/100 for the Fisher’s test, 60/100 for the KS test and 91/100 for the
Wilcoxon test.
The KO results for protein secretion also include terms related to the type III secretion
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system (K03219, K03230, K03224, K03220, K03227, K03226), and has significant terms
related to intimin and Tir - Translocated intimin receptor - (K12784, K12790, bootstrap
87/100 in Fisher’s test, 100/100 in KS and Wilcoxon test), two virulence factors secreted
into the host through the type III secretion system.
Other results related to protein secretion are KO terms referring to both LEE-encoded
and non-LEE-encoded effectors, a pathogenicity island that includes intimin and Tir.
K12785, K12786, K12787, K12788, K16041 and K16042 are those significant under a
qvalue < 0.01, with bootstrap scores varying between 80/100 (K12788, Fisher’s test) and
100/100.
Urease activity (GO:0009039, GO:0019627, GO:0043419) was overrepresented for Fish-
er and Wilcoxon test at a significance level of qvalue < 0.01 (bootstrap score between
95/100 and 99/100), with KS test being significant at a qvalue < 0.05 only (qvalue =
0.0143, bootstrap score 55/100 at qvalue < 0.01). Related KO terms are significant
for Wilcoxon test at a qvalue < 0.01 (K01428, K01429, K01430, K03187, K03188 and
K03189 with bootstrap score of 95/100, and K03190 with bootstrap score of 67/100) and
significant for Fisher and KS tests at qvalue < 0.05 significance level only, with bootstrap
score (qvalue < 0.01) of 42/100 for Fisher and 57/100 for KS.
The terms related to virion parts seen in Table 5.6 weren’t significant at qvalue <
0.01 significance level, but other significant GO terms detail the mechanism in which viral
particles are employed by EHEC/EPEC lineages. GO:0039663 ”membrane fusion involved
in viral entry into host cell” (qvalue = 3.09e-06, Fisher’s exact test, 87/100 bootstrap
score) and GO:0019031 ”viral envelope” (qvalue = 3.06e-04, Fisher’s exact test, 94/100
bootstrap score) are representative of the mechanism at work. Three terms are significant
at qvalue < 0.01 for Fisher’s test only (GO:0019064, GO:0046718, GO:0039663), with no
related GO terms significant for KS test.
For iron ion transport, not all of the terms in Table 5.7 were significant. GO:0015091,
GO:0015408, GO:0072510 were significant for Wilcoxon test at a qvalue < 0.01, with a
bootstrap score of 94/100. Most of the related terms found in the first experiment were
not significant and had a low bootstrap score, often 0/100. The article by Ogura et al
refers to iron utilization systems being present in strains beyond the EHEC pathotype
[35], which is in accordance with these results.
A significant term was the presence of shiga toxin (K11006, K11007) for both Fisher’s
exact test and Wilcoxon-Mann-Whitney test, a result that wasn’t significant in the first
experiment. It had a bootstrap score of 85/100 for Fisher’s test and 87/100 for Wilcoxon,
with 15 total occurrences each in the EHEC/EPEC group and 3 occurrences in the other
23 pathogenic lineages.
5.2.2 Correlation analysis
As in the first experiment, a correlation analysis was performed to find GO and KO
terms that correlate with pathogenesis (GO:0009405), this time analyzing only pathogenic
lineages. A total of 92 terms correlated with pathogenesis with a Pearson Correlation
Coefficient (PCC) above 0.8, seen in Table 5.10, which contains all terms found in Table
5.8.
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Despite having 35 more terms listed than the previous correlation analysis, 26 of them
are closely related to another previously found. An example is hemolysis by symbiont
of host erythrocytes (GO:0019836), which has one more term related in the first experi-
ment (GO:0052331) and nine in this experiment (GO:0001897, GO:0001907, GO:0044003,
GO:0044004, GO:0051801, GO:0051817, GO:0051818, GO:0051883, GO:0052331).
Seven categories of terms were not present in the previous experiment: glycosamino-
glycan metabolic process (GO:0030203), peptidoglycan metabolic process (GO:0000270,
GO:0006022), cell wall organization or biogenesis (GO:0071554, GO:0044036), NADP+
binding (GO:0070401), nickel cation binding (GO:0016151), metallochaperone activity
(GO:0016530) and nitrogen cycle metabolic process (GO:0071941). These last two terms
were also significant for the three tests at a significance level of qvalue < 0.05. NADP+
binding (GO:0070401) was only significant for Wilcoxon test at the same significance level,
while the remaining terms were significant for both KS and Wilcoxon.
Term PCC Description
K12788 0.938 espH; LEE-encoded effector EspH
K03220 0.927 yscD, sctD; type III secretion protein D
K12785 0.927 espG, virA; LEE-encoded effector EspG
K12786 0.927 espF; LEE-encoded effector EspF
K12787 0.927 map; LEE-encoded effector Map
K03224 0.922 yscN, sctN, hrcN; ATP synthase in type III secretion protein N
[EC:3.6.3.14]
GO:0072593 0.921 reactive oxygen species metabolic process
GO:0032880 0.909 regulation of protein localization
GO:0050708 0.909 regulation of protein secretion
GO:0051046 0.909 regulation of secretion
GO:0051223 0.909 regulation of protein transport
GO:0060341 0.909 regulation of cellular localization
GO:0070201 0.909 regulation of establishment of protein localization
GO:1903530 0.909 regulation of secretion by cell
GO:0051049 0.904 regulation of transport
GO:0051704 0.898 multi-organism process
GO:0004842 0.898 ubiquitin-protein transferase activity
GO:0019787 0.898 ubiquitin-like protein transferase activity
GO:0008234 0.898 cysteine-type peptidase activity
GO:0016567 0.893 protein ubiquitination
GO:0032446 0.893 protein modification by small protein conjugation
GO:0070647 0.893 protein modification by small protein conjugation or removal
GO:0072519 0.893 parasitism
K03221 0.883 yscF, sctF; type III secretion protein F
GO:0006801 0.882 superoxide metabolic process
GO:0004784 0.882 superoxide dismutase activity
GO:0016721 0.882 oxidoreductase activity, acting on superoxide radicals as acceptor
K04565 0.882 SOD1; superoxide dismutase, Cu-Zn family [EC:1.15.1.1]
K12789 0.881 tccP; Tir-cytoskeleton coupling protein
K16042 0.880 nleH; non-LEE-encoded effector NleH
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Table 5.10 – Correlation of GO:0009405 ”pathogenesis” with other terms in E. coli.
Term PCC Description
K03219 0.880 yscC, sctC; type III secretion protein C
K03230 0.880 yscV, sctV, hrcV; type III secretion protein V
K09953 0.877 lpxR; lipid A 3-O-deacylase
K12784 0.877 tir; translocated intimin receptor
K12790 0.877 eae; intimin
K16041 0.877 nleA; non-LEE-encoded effector NleA
K13743 0.867 ipgB2; protein IpgB2
GO:0071941 0.865 nitrogen cycle metabolic process
K03227 0.859 yscS, sctS, hrcS; type III secretion protein S
K10938 0.853 acfC; accessory colonization factor AcfC
GO:0000270 0.849 peptidoglycan metabolic process
GO:0030203 0.849 glycosaminoglycan metabolic process
K03225 0.847 yscQ, sctQ, hrcQ; type III secretion protein Q
K03226 0.846 yscR, sctR, hrcR; type III secretion protein R
GO:0044036 0.845 cell wall macromolecule metabolic process
K03222 0.843 yscJ, sctJ, hrcJ; type III secretion protein J
GO:0004197 0.841 cysteine-type endopeptidase activity
K07497 0.841 K07497; putative transposase
GO:0071554 0.839 cell wall organization or biogenesis
K07804 0.837 pagC; putatice virulence related protein PagC
GO:0032879 0.836 regulation of localization
GO:0015031 0.830 protein transport
GO:0006022 0.830 aminoglycan metabolic process
GO:0008104 0.827 protein localization
GO:0045184 0.827 establishment of protein localization
GO:0005576 0.817 extracellular region
K07484 0.813 K07484; transposase
GO:0070401 0.805 NADP+ binding
GO:0016151 0.802 nickel cation binding
GO:0020002 0.802 host cell plasma membrane
GO:0033644 0.802 host cell membrane
GO:0044218 0.802 other organism cell membrane
GO:0044279 0.802 other organism membrane
GO:0001897 0.801 cytolysis by symbiont of host cells
GO:0001907 0.801 killing by symbiont of host cells
GO:0019836 0.801 hemolysis by symbiont of host erythrocytes
GO:0044003 0.801 modification by symbiont of host morphology or physiology
GO:0044004 0.801 disruption by symbiont of host cell
GO:0051801 0.801 cytolysis in other organism involved in symbiotic interaction
GO:0051817 0.801 modification of morphology or physiology of other organism in-
volved in symbiotic interaction
GO:0051818 0.801 disruption of cells of other organism involved in symbiotic interac-
tion
GO:0051883 0.801 killing of cells in other organism involved in symbiotic interaction
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Table 5.10 – Correlation of GO:0009405 ”pathogenesis” with other terms in E. coli.
Term PCC Description
GO:0052331 0.801 hemolysis in other organism involved in symbiotic interaction
GO:0030597 0.801 RNA glycosylase activity
GO:0030598 0.801 rRNA N-glycosylase activity
K11006 0.801 stxA; shiga toxin subunit A
K11007 0.801 stxB; shiga toxin subunit B
GO:0018307 0.800 enzyme active site formation
GO:0019627 0.800 urea metabolic process
GO:0004143 0.800 diacylglycerol kinase activity
GO:0016530 0.800 metallochaperone activity
K00901 0.800 dgkA, DGK; diacylglycerol kinase (ATP) [EC:2.7.1.107]
K01428 0.800 ureC; urease subunit alpha [EC:3.5.1.5]
K01429 0.800 ureB; urease subunit beta [EC:3.5.1.5]
K01430 0.800 ureA; urease subunit gamma [EC:3.5.1.5]
K03187 0.800 ureE; urease accessory protein
K03188 0.800 ureF; urease accessory protein
K03189 0.800 ureG; urease accessory protein
K03760 0.800 eptA; lipid A ethanolaminephosphotransferase [EC:2.7.8.-]
GO:0043419 0.800 urea catabolic process
GO:0009039 0.800 urease activity
Table 5.10: Correlation of term ”pathogenesis” (GO:0009405)
with other terms in GO and KO (second experiment), for
R > 0.8.
5.2.3 Hierarchical clustering and distributions
An hierarchical clustering was performed for each statistical test, following the same
procedure as in the first experiment, seen in Figure 5.7. The pattern observed in the
heatmaps matches the grouping criteria adopted for the genomes, with the EHEC/EPEC
strains clustered together in most of the tests and having the overrepresented terms in
abundance (red), while the remaining pathogenic lineages show the majority of these
terms near or below the mean.
The exception is the heatmap for KO terms in the Fisher’s exact test results, where
three genomes (Xuzhou and two O55:H7 lineages) cluster closer to lineages of the other
group despite showing a pattern more similar to the remaining EHEC/EPEC strains (data
not shown).
The other pattern is the lineage O127:H6 (strain E2348/EPEC), which isn’t in the test
group due to its clustering in the first experiment, in Figure 5.3. Here, it often clusters far
from the EHEC/EPEC group, with the exception of the Fisher’s exact test for GO terms
(Figure 5.7). It possesses more overrepresented terms in abundance than the lineages of
the background group, though never as many terms as the EHEC/EPEC test group.
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Figure 5.7: Heatmap for 25 significant GO terms (qvaule < 0.05) for the Fisher’s ex-
act test, with the pattern matching the EHEC/EPEC grouping criteria adopted in this
analysis. One EPEC lineage that wasn’t included in the test group due to the pattern
observed in Figure 5.3 clusters together with the other EHEC/EPEC lineages here and
has more similarities to them than to the other pathotypes. Green parts indicate low nor-
malized frequency of a term (below 2 standard deviations), red indicates high normalized
frequency (above 2 standard deviations). The blue/red bar on the left indicates whether
the lineage is pathogenic (blue, test group) or free-living (red, background group).
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5.3 Third experiment: pathogenicity mechanisms in
plasmids
The objective of this final experiment is to evaluate the contribution of the plasmids car-
ried by E. coli strains to pathogenicity. It uses the protein annotation from the plasmids
only, analyzing whether the plasmids of the pathogenic E. coli lineages carry considerably
more virulence factors than those carried by the free-living lineages. All of the 50 lineages
used in the first experiment are analyzed here, with the same groups of lineages of the
first experiment, having an empty annotation for the strains without any plasmids.
5.3.1 Number of plasmids
A first analysis studies the number of plasmids between pathogenic and free-living strains
of E. coli, looking for a statistically significant difference in their number and distribution.
We use a simple, customized annotation to express the presence and number of plasmids
in each lineage.
The annotation uses a one-term ontology, in which the term indicates the presence of
a plasmid in the organism. The number of elements is equal to the maximum number
of plasmids carried by a single organism among the 50 E. coli strains. In this case, the
maximum number of plasmids was six; the number of elements in a lineage annotated
with this term was equal the number of plasmids it carries.
This custom ontology was created to conform to the implicit assumption of functional
annotations that a single element can’t have more than one instance of the same term.
Each element represents the possibility of having a plasmid inside the cell, limited to the
maximum number observed in any strain within the dataset. This procedure is general
enough for other cases where the number of an element is the matter of significance, not
only to plasmids.
We found the number of plasmids to be overrepresented in pathogenic E. coli by the
three statistical tests, with varying bootstrap scores. Its distribution is seen in Figure
5.8, in which more than 60% of the free-living lineages studied had no plasmids, against
roughly 25% of the pathogenic lineages.
Test qvalue Bootstrap
Fisher 7.06e-04 73/100
KS 8.06e-03 65/100
Wilcoxon 3.55e-03 81/100
Table 5.11: Overrepresentation in number of plasmids in
pathogenic E. coli (bootstrap for qvalue < 0.05).
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Figure 5.8: Histogram for the number of plasmids in pathogenic and free-living E. coli.
5.3.2 Significance Analysis - Gene Ontology and KEGG Orthol-
ogy
The plasmids had their proteome annotation analyzed to study their role in E. coli patho-
genesis, without the inclusion of chromosomal proteome. Both Gene Ontology and KEGG
Orthology annotation were used in this study.
For Gene Ontology, 27 terms were overrepresented for Fisher’s exact test at a signif-
icance level of qvalue < 0.05, with 98 for KS test and 197 for Wilcoxon-Mann-Whitney
test. At a significance level of qvalue < 0.01, 19 GO terms were significant for Fisher’s
test and none for KS and Wilcoxon tests.
A result that relates to the previously found significant GO terms is those related
to protein secretion (GO:0046903, GO:0009306, GO:0032940, GO:0015628, GO:0015627),
including terms related to protein transport and localization. All of these terms were
significant for Fisher’s exact test at a significance level of qvalue < 0.05, had a high
bootstrap score (qvalue < 0.05) and detail the mechanism as containing proteins of the
type II system. Only one related term was significant for KS test (GO:0005215 transporter
activity) at qvalue < 0.05, while multiple related terms were significant for Wilcoxon test.
Another result was DNA integration (GO:0015074) being significant in Wilcoxon and
KS tests for qvalue < 0.05, having a bootstrap score (qvalue < 0.05) of 78/100 and 83/100,
respectively. None of the KO terms were significant (qvalue < 0.05) in any of the three
tests, having bootstrap scores (qvalue < 0.05) below 45/100 in all cases.
ID qvalue Bootstrap Definition
GO:0046903 3.11e-04 94/100 secretion
GO:0009306 3.11e-04 94/100 protein secretion
GO:0032940 3.11e-04 94/100 secretion by cell
GO:0015628 8.34e-04 96/100 protein secretion by the type II secretion system
GO:0015627 8.34e-04 96/100 type II protein secretion system complex
Table 5.12: Terms related to secretion in the plasmids of
pathogen E. coli. Fisher’s exact test, bootstrap for qvalue
< 0.05.
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5.4 Parallelization and performance
We evaluated the parallelization performance of KOMODO2 on a multi-core server with
96 processors. Both the analysis with the GO terms and KO terms in the first experiment
were performed with increasing number of processors available, with the results in Figure
5.9 for parallelization of the enrichment analysis and bootstrap, the main bottlenecks of
the methodology.
We observed an exponential gain in the performance of KOMODO2 as the number
of processors available increased, which is observed as a linear pattern in a log-log plot.
This pattern eventually reaches a saturation point, in which the parallelization gains do
not compensate for the additional overhead from managing task allocation.
The parallelization gain reached a maximum of 12 times the speed of a sequential
run. The sequential analysis for GO terms took, on average, 2 hours and 35 minutes,
which was reduced to slightly less than 40 minutes for four processors and 25 minutes
for eight cores. The times for additional processors varied between 13 and 20 minutes
(gain between 8 and 12 times) after 16 processors, where the analysis started to show
a saturation pattern. Similar results were seen for the analysis with KO terms, which
showed a 50-minute sequential time reduced up to 4.5 minutes, with a gain of 11 times.
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Figure 5.9: Time benchmark for the first experiment, with the run time for the analysis of
GO terms (left side) and KO terms (right side) as a function of the number of processors.
The two bottom images show the same data in a log-log plot, with a linear pattern until
a point of saturation between 10 and 20 cores.
Chapter 6
Discussion
We performed three experiments seeking biologically insightful patterns about the mech-
anisms behind the pathogenic lineages of E. coli, using a dataset with 33 and 17 complete
genomes of pathogenic and free-living E. coli strains. The first experiment was done to
detect overall patterns when comparing these two groups. The pathogenic strains could
be further classified in phenotypically well-defined pathotypes, with distinct mechanisms
and ecological niches, and varying degrees of virulence. The second experiment focused
in the two most virulent pathotypes, EHEC (Enterohemorrhagic Escherichia coli) and
EPEC (Enteropathogenic Escherichia coli), since they appear to form a coherent group
in the first experiment, in order to further investigate the pathogenicity mechanisms in
this species. The third experiment was proposed to investigate the importance of plasmids
for pathogenicity in E. coli, as well as complementing the observations of the previous
experiment.
We also implemented several improvements that benefited from the data structure
designed for this tool and from the parallelization at several steps, reusing the information
of the enrichment analysis for all the subsequent steps. We did a last experiment to
specifically demonstrate how the parallelization schema improves the running time of the
analysis.
6.1 KOMODO2: biologically meaningful insights
In the heatmap for the Fisher’s exact test results (Figure 5.3), a notable pattern is the
subgroup of pathogenic lineages with high frequency of most of the significant terms.
These are mainly EHEC or EPEC lineages, known for their high virulence and for having
a larger chromosome size than other E. coli strains. This extra size explains the pattern
in the heatmap: it contains many virulence-related genes, most being specific to these two
pathotypes, encoded by mobile elements, which were integrated into their E. coli genome
[35]. The non-mobile parts of their genome are known to have few genes specific to their
pathotypes.
We found a grouping pattern on our heatmap (Figure 5.3) that comprises virtually all
EHEC/EPEC genomes analyzed in our study. Due to this reason, as well as the results of
Ogura et al. [35] about the convergent evolution of the EHEC pathogenicity, we decided
65
CHAPTER 6. DISCUSSION 66
to compare the group of EHEC/EPEC lineages vs. all other pathogenic E. coli to verify
if we would observe the same results and, therefore, demonstrate KOMODO2 is able to
find and expand such observations.
One of the first results was the protein ubiquitination, a biological process that tar-
gets proteins for degradation, and related to many cell processes, such as defense against
pathogens, cellular survival, autophagy and DNA repair. It is a prime mechanism mod-
ulated by pathogenic organisms to subvert the cell’s resources and machinery, prevent
phagocytosis [44, 45, 46] and inhibit apoptosis [47].
In the first experiment, this result had a high bootstrap value for its terms in the
Fisher’s exact test, as well as some of the lowest qvalues, meaning a difference as extreme
as observed between the two groups has a low chance to be seen if their distributions
are identical. Furthermore, protein ubiquitination (GO:0016567) wasn’t found among the
proteins of the free-living E. coli, indicating that this is a trait specific to pathogenicity in
E. coli. The KS and Wilcoxon-Mann-Whitney tests, however, did not have these terms as
overrepresented due to the number of genomes with no occurrences among the pathogenic
lineages, as seen in Figure 5.4.
In the second experiment, this mechanism was significantly overrepresented, with a
100/100 bootstrap score, in all the three tests. Additionally, the ten EHEC/EPEC strains
had a total of 101 occurrences of protein ubiquitination (GO:0016567), while the remaining
23 pathogenic strains combined had only 1 occurrence. This mechanism is among the
EHEC/EPEC-specific virulence genes mentioned by Ogura et al [35], being one of the
responsible factors for high virulence in this species, but not essential for the ability to
cause a disease.
The plasmid experiment did not find occurrences of ubiquitination-related terms,
meaning this type of mechanism isn’t acquired through plasmids; rather, it is present
in the chromosomal part of the pathogenic lineages. This reinforces that the presence
of ubiquitination-related terms is a specific trait for the EHEC/EPEC pathotypes, who
possess an additional chromosomal part with EHEC/EPEC-specific virulence genes [35],
rather than a general rule for E. coli pathogenicity.
Another result found in our experiments was the conversion of urea into ammonia, a
process that hinders the immune system by raising the pH above its optimal value and
that provides an additional source of nitrogen [48]. It is believed that it can increase
resistance to the acidic environment of the intestinal tract and help colonize it, giving an
advantage in relation to the free-living bacteria found in the gut flora [49].
Terms related to urea metabolism (GO:0018307, GO:0043419, GO:0009039) and re-
lated proteins (K01428, K01429, K01430, K03187, K03188, K03189) were found mainly
in EHEC (Enterohemorrhagic E. coli) and EPEC (Enteropathogenic E. coli) lineages,
with 23 occurrences in the second experiment compared to the 3 occurrences among the
other pathogenic E. coli. This pattern is seen in the heatmap for the Fisher’s exact test
(Figure 5.3) and in the related histograms (Figure 5.4), the latter in particular showing a
bimodal distribution for the pathogenic group, the first mode in the zero occurrences.
This term wasn’t present in high amounts among UPEC (Uropathogenic Eschericha
coli) lineages, which suggests they don’t rely on the same benefits that EHEC and EPEC
strains use to colonize their respective environments. As mentioned by Wiles et al., a
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main factor for UPEC to withstand the urine in the urinary tract is the ability to bind
host tissues instead [50], therefore relying on an alternative mechanism.
The bootstrap value for the urea metabolism is 91/100, but 76/100 for the urease
activity, in the Fisher’s exact test, suggesting the urease activity itself is not a general trait
of pathogenicity for this species. This is further supported by the hierarchical clustering
(Figure 5.3) and the histogram (Figure 5.4), which shows that most of the occurrences of
this term is concentrated in EHEC/EPEC strains, with most of the other lineages having
no occurrences of this term among its proteins.
The second experiment supports this hypothesis, having a bootstrap score (qvalue
< 0.01) between 95/100 and 99/100 for related GO terms (GO:0009039, GO:0019627,
GO:0043419) in the Fisher’s exact test and the Wilcoxon-Mann-Whitney test. The third
experiment found no occurrence of urea metabolism terms, meaning any known protein
related to urease is found in the chromosomal part of the EHEC/EPEC lineages, a result
in accordance with Ogura et al finding about the presence of a large integrative element
containing urease operons in EHEC strains [35].
An additional result is DNA integration, thought to have a major role in the acquisition
of pathogenicity genes, as EHEC strains have mobile elements that carry equal or similar
virulence genes. It is also known that most EHEC/EPEC-specific genes are encoded
by mobile elements, with few EHEC/EPEC-specific genes present in the rest of their
chromosome [35].
This term is more evenly distributed than the previous ones and was significant in
the three statistical tests. Its distribution for the test group, seen in the histogram of
Figure 5.4, is stochastically greater than the background’s distribution and indicates no
cases with zero occurrences among the pathogenic lineages. Although also present in the
free-living lineages, its accumulation can be described as a general pattern for pathogenic
lineages by the KS and Wilcoxon-Mann-Whitney tests.
This is supported in the experiment with EHEC/EPEC lineages, as DNA integration
wasn’t significant in any of the three tests and had a low bootstrap score (qvalue < 0.01)
in all of them, meaning it isn’t a specific mechanism for these two pathotypes. The
experiment with plasmids also indicate it as significant in KS and Wilcoxon test (qvalue
< 0.05), meaning it isn’t restricted to the chromosome and, therefore, is found outside
the EHEC/EPEC-specific virulence genes.
Some of the results refer to the protein secretion method adopted by pathogen E. coli.
It is defined by adherence receptors produced by the E. coli that, once injected in the
host cell, attach to its cell membrane and connects with the pathogen’s own receptors,
letting it adhere to the host. The secretion system known as ”type III”, characterized
for its ’needle and syringe’ structure, is the most associated to the species and allows
the injection of effector proteins [34] to alter the cell’s processes. This includes proteins
related to ubiquitination and DNA integration, the latter found in pathogenicity islands,
that allows for insertions of bacteria DNA in the host’s sequence [42] [51].
The protein secretion itself wasn’t significant in the first experiment for the Fisher’s
exact test, despite its abundance in the pathogenic lineages, due to the relative abundance
in the free-living strains. In the second experiment, however, the difference observed be-
tween EHEC/EPEC and other pathotypes was statistically significant for the Fisher’s test,
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demonstrating KOMODO2 is able to find subtle differences according to the biological
question under analysis.
Virion-related terms (GO:0019028, GO:0019012, GO:0044423) were found significantly
overrepresented in the three statistical tests of the first experiment, suggesting that viral
proteins play an important part of the process of pathogeny in E. coli, not just in a few
strains. In fact, several virulence factors are carried together with insertion elements,
such as viruses, in several pathogenic bacteria and in E. coli in particular, being im-
portant players for the horizontal transfer of pathogenicity elements [35]. In the second
experiment, two terms detailed the mechanism at work for EHEC/EPEC pathotypes:
membrane fusion involved in viral entry into host cell (GO:0039663) and viral envelope
(GO:0019031), both significant for Fisher’s exact test only.
The significance of these three terms in the second experiment wasn’t as extreme as
in the first due to the relative abundance in all pathogenic lineages, a result expected
from the fact that, in the first experiment, the three terms were also significant in the
KS and Wilcoxon test and had a high bootstrap score in all of the three tests (97/100 in
KS, 100/100 in Fisher and Wilcoxon, qvalue < 0.05). This implies the presence of a viral
capsid is a general trait for pathogenicity in E. coli.
Another investigated result was the presence of terms related to iron acquisition, an
important ability for pathogens to multiply within the host. Iron cations are essential
for almost all life process, such as respiration, and are found in a very low concentration
in the host environment due to the control it exerts with proteins like hemoglobin and
lactoferrin. As such, pathogenic bacteria are under selective pressure for ways to obtain
it from the host. Proteins related to it (siderophores, yersiniabactin) are known to be
important in uropathogenic E. coli and are associated to increased virulence due to the
enhanced ability to multiply and colonize the urinary tract [52] [53].
Unlike most other results, this mechanism was not found to be characteristic of
pathogenic E. coli only, since iron is an essential component for life. As seen in the
histogram in Figure 5.4, all the 50 E. coli strains had at least 9 occurrences of the term
”iron ion transport” (GO:0006826). The presence in the pathogenic lineages is stochasti-
cally dominant over the presence in free-living ones, making it significant in the Wilcoxon
test in the first experiment, but not in the Fisher’s test, with EHEC/EPEC showing few
changes relative to the other pathogenic lineages.
The second experiment found other mechanisms that weren’t significant in the first ex-
periment, such as single-species biofilm formation (GO:0044010), ATPase activity (GO:00
44769, GO:0036442, GO:0046961), hemolysis in another organism (GO:0044179, GO:0044
364, GO:0031640, GO:0001906, GO:0051715, GO:0035821) and Shiga toxin (K11006,
K11007), as well as many terms related to both LEE and non-LEE-encoded effectors,
where LEE stands for Locus of Enterocyte Effacement. This is an indication that these
mechanisms, known to have virulence properties [35, 54, 55, 56], are specific to either (or
both) EHEC or EPEC strains, a result consistent with the scientific literature.
We also evaluated the distinct content of plasmids from pathogenic and free-living
lineages, providing, to the best of our knowledge, the first statistically sound evidence
that plasmids from pathogenic E. coli do carry more virulence factors.
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6.2 KOMODO2: tool analysis
The enrichment analysis identified virulence factors known in the scientific literature,
with results varying between statistical tests. These differences don’t stray away from
known virulence factors, and the varying results reflect two aspects of the experiment: the
heterogeneity of the E. coli lineages and the premises of each test about what difference
to seek.
The first aspect is reflected in the E. coli pathogenicity subgroups, or pathotypes,
which vary in lethality and targeted region. For instance, UPEC (Uropathogenic E.
coli) is a subgroup that targets the urinary tract, while the ETEC (Enterotoxigenic E.
coli) affects the intestinal tract, with symptoms varying from mild discomfort to severe
cholera-like syndrome. The EHEC (Enterohemorrhagic E. coli) lineages are of particular
virulence, characterized by hemorrhagic colitis (bloody diarrhea) and the production of
Shiga-like toxins. This heterogeneity can result in multimodal distributions, as seen for
”urease activity” (GO:0009039) in Figure 6.1, due to certain mechanisms being specific to
a pathotype.
Within this heterogeneity, Kolmogorov-Smirnov and Wilcoxon-Mann-Whitney tests
were able to find more statistically significant terms representing general mechanisms of
E. coli pathogenicity, as they are less susceptible to outliers. Even in cases with extreme
outliers for one group, they can identify cases when the test group is stochastically higher
and dismiss those that don’t apply as a general rule, as seen in Figure 6.1. Because the
Fisher’s exact test doesn’t distinguish if a term’s count is concentrated in a few genomes
or well distributed over all genomes of the group, its results aren’t immediately applicable
as a general case for the studied character and require additional information to decide if
the result is specific to a subgroup.
We added the correlation analysis to provide a different investigation method: it
identifies terms that most follows the accumulation of another term, even if they aren’t
representative as a general, or essential, term for the difference between the test group and
the background group. For the case of pathogenesis (GO:0009405) in Table 5.8, not every
term was found as both significant and correlated to pathogenesis. Some of the terms
were specific to a few lineages in one group, such as the Shiga toxin (K11006 and K11007)
and hemolysis (GO:0019836 and GO:0052331), and are known to be present in the most
virulent lineages [55], but were not present in high enough numbers to show significance
in any of the three tests of the first experiment. These results can be interpreted as an
indication that these terms can increase the pathogenicity and virulence of E. coli, but
aren’t needed for a lineage to be pathogenic, a hypothesis not immediately clear with the
enrichment analysis alone.
Not all mechanisms listed as significant were also highly correlated with pathogenesis
either. Virion (GO:0019012), DNA integration (GO:0015074) and porins (K16076) had
a PCC lower than 0.8. This may mean that, although important for pathogeny, either
their number doesn’t improve this capability directly, or its frequency varies considerably
between lineages.
The hierarchical clustering was included to help identifying biases in the dataset and
in the ontology, as mentioned in Section 4.5. Examples of biases that can be easily
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Figure 6.1: Examples of distributions of two GO terms, from the results of the first exper-
iment. The term ”urease activity” presents a bimodal distribution for term GO:0009039
in the test group, with the rightmost mode creating enough divergence for significance in
the Fisher’s exact test. The test group has a node for no presences of the term, meaning
it isn’t a general aspect of pathogenic E. coli, just concentrated in a few ones. The term
”iron ion transport” shows a higher stochastic mean for the test group, displacing the dis-
tribution to the right and being significant for both KS test and Wilcoxon-Mann-Whitney
test.
identified are groups with unique patterns, subgroups with some significant terms not
being applicable to them, and cases when one organism has an abnormally high frequency
for all terms, as expected in the case for GO terms in model organisms. The two first
biases were present between EHEC/EPEC E. coli lineages relative to other pathogenic
strains and seen in Figure 5.3. It was capable of revealing patterns between terms and
organisms for the results of the Fisher’s Exact test, and evidenced the presence of a
subgroup with a particularly high frequency of terms for the test group, explained by the
additional chromosome content of these lineages [35]. This led to the second experiment
to investigate this pattern and possible additional mechanisms, which would confirm some
of the hypothesis raised from the interpretation of the results from the significance and
correlation analysis.
We also added the histograms to visualize the distributions of both groups, normalized
to avoid distortions from unequal group size, and they helped explaining why some results
would wield a term as significant in one test and not in another. Like the hierarchical
clustering, they could reveal differences within subgroups by the presence of multimodal
distributions and spot the presence of possible outliers or subgroups that merit investiga-
tion. Additionally, they inform the absolute occurrences of a term in each group, which
allows us to identify whether a term is practically exclusive for a group (protein ubiqui-
tination), subgroup (urease activity), or generalized in both groups (iron ion transport),
as seen in Figure 5.4.
The purpose of selecting an ontology was to allow complementary analysis on the
dataset, since each ontology is defined within a given scope and can introduce different
biases in the analysis. Each ontology can also offer unique tools and supplementary
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resources, which may be familiar or of interest for the user. In our experiments, adding
KEGG Orthology allowed the detection of specific LEE and non-LEE-encoded effector
proteins, as well as the presence of Shiga toxins, as mechanisms of pathogenicity (ability
to cause a disease) and virulence (severity of the pathology) among E. coli strains, and
offered additional details for the GO terms representing more general functions associated
to them.
An example of ontology’s bias is the one towards GO term accumulation in model
organisms (example in Table 6.1), as the ontology is based on experimental evidence. This
is explained by the ”open world assumption”: the absence of a GO term doesn’t mean
absence of that function [57], it only means it wasn’t experimentally confirmed or predicted
by automatic annotation. By having a higher number of experiments conducted, model
organisms have more genes, proteins and functions discovered to be annotated to the
genome as GO terms. This feature provides the option to compare results with different
ontologies, as to identify possible biases and expand the ontology’s scope, allowing other
sources of information to complement the annotation with your original ontology.
Organism Proteins GO terms GO/protein ratio
D. ananassae 14968 18919 1.26
D. erecta 14881 18563 1.25
D. grimshawi 14754 19061 1.29
D. melanogaster (model organism) 20049 95655 4.77
D. mojavensis 14525 18191 1.25
D. persimilis 16754 19077 1.14
D. pseudoobscura pseudoobscura 16756 21492 1.28
D. sechellia 16138 19416 1.20
D. simulans 15359 17792 1.16
D. virilis 14456 18541 1.28
D. willistoni 15447 18932 1.23
D. yakuba 15954 19195 1.20
Table 6.1: Drosophila protein/term count. Twelve
species of genus Drosophila with the known number of
proteins and how many GO terms are annotated to them.
D. melanogaster is a model organism, with more known
proteins and functions annotated than other species of
the same genus.
The possibility to use a customized ontology was added to allow for non-standard
analysis, using ontologies not supported by Bioconductor [28]. We used this feature
to survey a possible difference in the number of plasmids between pathogenic and free-
living E. coli lineages, finding support for this claim for the first time, to the best of our
knowledge.
KOMODO2 adds several statistical tools to allow users to quantify and objectively
evaluate genomic data. The previous studies of Lobo et al. and Cai et al. relied exclu-
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sively on qvalues. KOMODO2, on the other hand, implements qvalues plus several other
metrics, such as effect size, data bootstrapping and correlation analysis. Bootstrapping
in particular allowed us to find heterogeneous term distributions inside our case study,
and suggested additional experiments, such as in the EHEC/EPEC case.
Finally, the data structure implemented in KOMODO2 allows for multiple types of
analyses (e. g. correlation, hierarchical clustering) to be performed from the information
processed in the enrichment analysis, avoiding loss of performance from recomputing the
same data. Additionally, this structure supports a parallel design, allowing KOMODO2
to analyze large-scale genomic datasets in a feasible time. Our software also produces
several types of graphical outputs, such as heatmaps and histograms, to allow users to
perform exploratory analyses. In the specific case of our first experiment, we were able to
find the EHEC/EPEC group and decided to further evaluate it.
Chapter 7
Conclusion and Future work
The scenario of wealth of comparative genomics data contrasts with the lack of specialized
software to extract biologically meaningful and statistically sound information from the
patterns observed in such data. KOMODO2 aims at filling this gap, allowing users to
formulate and investigate biologically meaningful hypotheses from structured comparative
genomics data available at public databases and resources in a feasible time.
The work by Ogura et al. [35] is an archetypal example of a comparative genomics
study. It found potentially interesting data distribution patterns when comparing EHEC
and EPEC E. coli against other phylogenetically related lineages, but it was not able to
provide a statistically rigorous test to prove it, as can be seen in the statement below:
”The genomic locations of the virulence-related genes shared by the EHEC strains in-
dicate that the major forces driving the acquisition of these genes are mobile
genetic elements; we found that the EHEC strains contain many similar mobile elements
that carry the same or very similar virulence genes. However, such elements present in
each EHEC strain, including LEEs, lambdoid phages, some IEs, and pE- HEC plasmids,
exhibited significant structural diversities.”
In this statement, the authors claimed the relationship between virulence-related fea-
tures and genetic mobile elements, eventually suggesting a causal link between them, but
they did not provide a statistical analysis to prove it (they did not provide any signif-
icance analysis, for instance). We used a dataset comprising pathogenic and free-living
E. coli lineages that is conceptually similar to the one used by Ogura et al. to evaluate
KOMODO2 and we were able to find virtually the same biological findings of this study;
this time with statistical support. KOMODO2 found evidence that this may be true in-
deed, as can be seen in our significance experiments and especially in the grouping pattern
observed in the heatmap for the experiment one, where pathogenesis (GO:0009405) term
groups together with several virion-related terms, suggesting there is a link between those
two groups of biological phenomena.
Future improvements in our tool will include the addition of other types of graphical
output commonly used to analyze genomic data, such as volcano plots. Other possible
improvement is the distribution of jobs in a cluster, further improving the parallelization
schema implemented in our software. The final results produced by KOMODO2, as well
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as the information of the intermediate steps, could also be available and distributed as
web content, allowing users to independently verify experiments and share their results
in a standardized manner. The web distribution of analyses done using KOMODO2 will
also allow users to perform meta-analysis and eventually produce new knowledge.
KOMODO2 is, to the best of our knowledge, the first bioinformatics tool to allow users
to perform exploratory, statistically sound, biologically meaningful comparative genomics
analysis in a feasible time, ultimately helping users to formulate and critically evaluate
hypotheses regarding the patterns of distributions of genomic elements across genomes.
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Appendix A
Appendix
A.1 Escherichia coli lineages
A.1.1 Pathogenic lineages
Lineages Cromossomal Plasmids
(strain 55989 / EAEC) NC_011748 -
(strain UM146) NC_017632 NC_017630
(strain UTI89 / UPEC) NC_007946 NC_007941
APEC O78 NC_020163 -
LF82 NC_011993 -
NA114 NC_017644 -
O1:K1 / APEC NC_008563 NC_009837
NC_009838
O6:H1 (strain CFT073 / ATCC 700928 / UPEC) NC_004431 -
O6:K15:H31 (strain 536 / UPEC) NC_008253 -
O7:K1 (strain IAI39 / ExPEC) NC_011750 -
O7:K1 str. CE10 NC_017646 NC_017647
NC_017648
NC_017649
NC_017650
O17:K52:H18 (strain UMN026 / ExPEC) NC_011751 NC_011749
NC_011739
O18:K1:H7 (strain IHE3034 / ExPEC) NC_017628 -
O26:H11 (strain 11368 / EHEC) NC_013361 NC_013362
NC_013363
NC_013369
NC_014543
O44:H18 (strain 042 / EAEC) NC_017626 NC_017627
O45:K1 (strain S88 / ExPEC) NC_011742 NC_011747
O55:H7 (strain CB9615 / EPEC) NC_013941 NC_013942
O55:H7 str. RM12579 NC_017656 NC_017653
NC_017654
NC_017655
NC_017657
NC_017658
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Table A.1 – Pathogenic E. coli lineages.
Lineages Cromossomal Plasmids
O78:H11 (strain H10407 / ETEC) NC_017633 NC_017721
NC_017722
NC_017723
NC_017724
O83:H1 (strain NRG 857C / AIEC) NC_017634 NC_017659
O103:H2 (strain 12009 / EHEC) NC_013353 NC_013354
O104:H4 (strain 2009EL-2050) NC_018650 NC_018651
NC_018652
NC_018654
O104:H4 (strain 2009EL-2071) NC_018661 NC_018662
NC_018663
O104:H4 (strain 2011C-3493) NC_018658 NC_018659
NC_018660
NC_018666
O111:H- (strain 11128 / EHEC) NC_013364 NC_013365
NC_013366
NC_013367
NC_013368
NC_013370
O127:H6 (strain E2348/69 / EPEC) NC_011601 NC_011602
NC_011603
O139:H28 (strain E24377A / ETEC) NC_009801 NC_009791
NC_009790
NC_009789
NC_009788
NC_009787
NC_009786
O157:H7 (strain EC4115 / EHEC) NC_011353 NC_011351
NC_011350
O157:H7 (strain TW14359 / EHEC) NC_013008 NC_013010
O157:H7 str. EDL933 NC_002655 NC_007414
O157:H7 str. Sakai NC_002695 NC_002127
NC_002128
UMNK88 NC_017641 NC_017639
NC_017640
NC_017642
NC_017643
NC_017645
Xuzhou21 NC_017906 NC_017903
NC_017907
Table A.1: Pathogenic E. coli lineages.
A.1.2 Free-living lineages
Lineages Cromossomal Plasmids
(strain ATCC 8739 / DSM 1576 / Crooks) NC_010468 -
(strain ATCC 9637 / CCM 2024 / DSM 1116 / NCIMB 8666
/ NRRL B-766 / W)
NC_017635 NC_017636
NC_017637
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Table A.2 – Free-living Escherichia coli lineages.
Lineages Cromossomal Plasmids
(strain ATCC 33849 / DSM 4235 / NCIB 12045 / K12 /
DH1)
NC_017625 -
(strain ATCC 55124 / KO11) NC_017660 NC_017661
(strain B / BL21-DE3) NC_012971 -
(strain B / REL606) NC_012967 -
(strain K12 / DH10B) NC_010473 -
(strain K12 / MC4100 / BW2952) NC_012759 -
(strain K12 / W3110 / ATCC 27325 / DSM 5911) NC_007779 -
(strain SE11) NC_011415 NC_011407
NC_011408
NC_011411
NC_011413
NC_011416
NC_011419
(strain SMS-3-5 / SECEC) NC_010498 NC_010488
NC_010487
NC_010486
NC_010485
O8 (strain IAI1) NC_011741 -
O9:H4 (strain HS) NC_009800 -
O81 (strain ED1a) NC_011745 -
O150:H5 (strain SE15) NC_013654 NC_013655
str. K-12 substr. MDS42 NC_020518 -
str. K-12 substr. MG1655 NC_000913 -
Table A.2: Free-living Escherichia coli lineages.
A.2 Escherichia coli (pathogenicity): Overrepresen-
tation
A.2.1 Fisher’s Exact test (GO)
ID qvalue Bootstrap Definition
GO:0009405 8.93e-18 100/100 pathogenesis
GO:0004842 1.88e-16 100/100 ubiquitin-protein transferase activity
GO:0016567 4.10e-14 100/100 protein ubiquitination
GO:0032446 4.10e-14 100/100 protein modification by small protein conjugation
GO:0072519 4.10e-14 100/100 parasitism
GO:0070647 1.83e-11 100/100 protein modification by small protein conjugation or re-
moval
GO:0019028 4.59e-08 99/100 viral capsid
GO:0019012 9.74e-08 99/100 virion
GO:0044423 9.74e-08 99/100 virion part
GO:0015074 5.88e-07 97/100 DNA integration
GO:0008821 3.13e-04 96/100 crossover junction endodeoxyribonuclease activity
GO:0016889 3.13e-04 96/100 endodeoxyribonuclease activity, producing 3’-
phosphomonoesters
GO:0019627 6.55e-04 91/100 urea metabolic process
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Table A.3 – Table of overrepresented terms in pathogenic E. coli lineages (Fisher).
ID qvalue Bootstrap Definition
GO:0050708 1.72e-03 92/100 regulation of protein secretion
GO:0051046 1.72e-03 92/100 regulation of secretion
GO:0044403 1.19e-02 67/100 symbiosis, encompassing mutualism through parasitism
GO:0044419 1.19e-02 67/100 interspecies interaction between organisms
GO:0043419 1.25e-02 76/100 urea catabolic process
GO:0009039 1.25e-02 76/100 urease activity
GO:0016894 1.39e-02 70/100 endonuclease activity, active with either ribo- or deoxyri-
bonucleic acids and producing 3’-phosphomonoesters
GO:0000746 1.39e-02 62/100 conjugation
GO:0009617 1.45e-02 68/100 response to bacterium
GO:0004197 1.45e-02 75/100 cysteine-type endopeptidase activity
GO:0006310 1.45e-02 64/100 DNA recombination
GO:0042742 1.52e-02 66/100 defense response to bacterium
Table A.3: Overrepresented GO terms in pathogenic E. coli lin-
eages under Fisher’s exact test, qvalue < 0.05.
A.2.2 Fisher’s Exact test (KO)
ID qvalue Bootstrap Definition
K07484 1.33e-07 93/100 K07484; transposase
K01160 3.36e-07 100/100 rusA; crossover junction endodeoxyribonuclease RusA
[EC:3.1.22.4]
K14744 3.46e-05 94/100 rzpD; prophage endopeptidase [EC:3.4.-.-]
K07497 2.99e-03 63/100 K07497; putative transposase
K01185 3.01e-02 57/100 E3.2.1.17; lysozyme [EC:3.2.1.17]
K05795 3.43e-02 65/100 terD; tellurium resistance protein TerD
Table A.4: Overrepresented KO terms in pathogenic E. coli lin-
eages under Fisher’s Exact test, qvalue < 0.05.
A.2.3 Kolmogorov-Smirnov test (GO)
ID qvalue Bootstrap Definition
GO:0004252 2.68e-03 100/100 serine-type endopeptidase activity
GO:0008907 2.68e-03 97/100 integrase activity
GO:0008821 2.68e-03 99/100 crossover junction endodeoxyribonuclease activity
GO:0016889 2.68e-03 99/100 endodeoxyribonuclease activity, producing 3’-
phosphomonoesters
GO:0009405 2.68e-03 100/100 pathogenesis
GO:0016998 4.41e-03 95/100 cell wall macromolecule catabolic process
GO:0051649 4.41e-03 99/100 establishment of localization in cell
GO:0000737 6.20e-03 95/100 DNA catabolic process, endonucleolytic
GO:0006308 6.20e-03 95/100 DNA catabolic process
GO:0016894 6.20e-03 96/100 endonuclease activity, active with either ribo- or deoxyri-
bonucleic acids and producing 3’-phosphomonoesters
GO:0019012 6.20e-03 97/100 virion
GO:0019028 6.20e-03 97/100 viral capsid
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Table A.5 – Table of overrepresented terms in pathogenic E. coli lineages (KS test).
ID qvalue Bootstrap Definition
GO:0044423 6.20e-03 97/100 virion part
GO:0004175 6.20e-03 95/100 endopeptidase activity
GO:0008236 1.16e-02 95/100 serine-type peptidase activity
GO:0017171 1.16e-02 95/100 serine hydrolase activity
GO:0030001 1.16e-02 93/100 metal ion transport
GO:0019867 1.34e-02 90/100 outer membrane
GO:0006807 1.34e-02 88/100 nitrogen compound metabolic process
GO:0044260 1.34e-02 89/100 cellular macromolecule metabolic process
GO:0090304 1.34e-02 88/100 nucleic acid metabolic process
GO:0001882 1.34e-02 89/100 nucleoside binding
GO:0001883 1.34e-02 89/100 purine nucleoside binding
GO:0017076 1.34e-02 90/100 purine nucleotide binding
GO:0032549 1.34e-02 89/100 ribonucleoside binding
GO:0032550 1.34e-02 89/100 purine ribonucleoside binding
GO:0032553 1.34e-02 89/100 ribonucleotide binding
GO:0032555 1.34e-02 89/100 purine ribonucleotide binding
GO:0035639 1.34e-02 89/100 purine ribonucleoside triphosphate binding
GO:0036094 1.34e-02 95/100 small molecule binding
GO:0097367 1.34e-02 90/100 carbohydrate derivative binding
GO:0009987 1.34e-02 86/100 cellular process
GO:0005488 1.34e-02 90/100 binding
GO:0097159 1.34e-02 87/100 organic cyclic compound binding
GO:1901363 1.34e-02 87/100 heterocyclic compound binding
GO:0006826 1.34e-02 90/100 iron ion transport
GO:0034641 1.34e-02 88/100 cellular nitrogen compound metabolic process
GO:0046483 1.34e-02 88/100 heterocycle metabolic process
GO:0051641 1.52e-02 95/100 cellular localization
GO:0043170 2.07e-02 82/100 macromolecule metabolic process
GO:0005524 2.07e-02 89/100 ATP binding
GO:0030554 2.07e-02 89/100 adenyl nucleotide binding
GO:0032559 2.07e-02 89/100 adenyl ribonucleotide binding
GO:0043168 2.07e-02 88/100 anion binding
GO:0006139 2.07e-02 85/100 nucleobase-containing compound metabolic process
GO:0006310 2.07e-02 82/100 DNA recombination
GO:0016020 2.07e-02 84/100 membrane
GO:0009279 2.07e-02 91/100 cell outer membrane
GO:0030312 2.07e-02 84/100 external encapsulating structure
GO:0000166 2.07e-02 87/100 nucleotide binding
GO:1901265 2.07e-02 87/100 nucleoside phosphate binding
GO:0044238 2.07e-02 85/100 primary metabolic process
GO:0090305 2.07e-02 88/100 nucleic acid phosphodiester bond hydrolysis
GO:1901360 2.07e-02 84/100 organic cyclic compound metabolic process
GO:0003677 2.07e-02 86/100 DNA binding
GO:0043086 2.10e-02 84/100 negative regulation of catalytic activity
GO:0003674 2.10e-02 87/100 molecular_function
GO:0015074 2.16e-02 88/100 DNA integration
GO:0071944 3.33e-02 68/100 cell periphery
GO:0006259 3.33e-02 78/100 DNA metabolic process
GO:0019748 3.33e-02 73/100 secondary metabolic process
GO:0044265 3.33e-02 82/100 cellular macromolecule catabolic process
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Table A.5 – Table of overrepresented terms in pathogenic E. coli lineages (KS test).
ID qvalue Bootstrap Definition
GO:0030313 3.33e-02 83/100 cell envelope
GO:0031975 3.33e-02 83/100 envelope
GO:0003676 3.33e-02 82/100 nucleic acid binding
GO:0004520 3.33e-02 78/100 endodeoxyribonuclease activity
GO:0004536 3.33e-02 79/100 deoxyribonuclease activity
GO:0006508 3.33e-02 82/100 proteolysis
GO:0044270 3.33e-02 83/100 cellular nitrogen compound catabolic process
GO:0044462 3.33e-02 83/100 external encapsulating structure part
GO:0000287 3.33e-02 66/100 magnesium ion binding
GO:0043167 3.33e-02 80/100 ion binding
GO:0008152 3.33e-02 80/100 metabolic process
GO:0006725 3.33e-02 83/100 cellular aromatic compound metabolic process
GO:0019222 3.33e-02 76/100 regulation of metabolic process
GO:0005576 3.33e-02 71/100 extracellular region
GO:0016741 3.33e-02 66/100 transferase activity, transferring one-carbon groups
GO:0009617 3.45e-02 73/100 response to bacterium
GO:0006163 3.97e-02 57/100 purine nucleotide metabolic process
GO:0042278 3.97e-02 56/100 purine nucleoside metabolic process
GO:0006152 3.97e-02 56/100 purine nucleoside catabolic process
GO:0006195 3.97e-02 56/100 purine nucleotide catabolic process
GO:0006753 3.97e-02 56/100 nucleoside phosphate metabolic process
GO:0009116 3.97e-02 57/100 nucleoside metabolic process
GO:0009117 3.97e-02 56/100 nucleotide metabolic process
GO:0009119 3.97e-02 56/100 ribonucleoside metabolic process
GO:0009141 3.97e-02 57/100 nucleoside triphosphate metabolic process
GO:0009143 3.97e-02 56/100 nucleoside triphosphate catabolic process
GO:0009144 3.97e-02 57/100 purine nucleoside triphosphate metabolic process
GO:0009146 3.97e-02 56/100 purine nucleoside triphosphate catabolic process
GO:0009150 3.97e-02 57/100 purine ribonucleotide metabolic process
GO:0009154 3.97e-02 56/100 purine ribonucleotide catabolic process
GO:0009164 3.97e-02 56/100 nucleoside catabolic process
GO:0009166 3.97e-02 56/100 nucleotide catabolic process
GO:0009199 3.97e-02 57/100 ribonucleoside triphosphate metabolic process
GO:0009203 3.97e-02 56/100 ribonucleoside triphosphate catabolic process
GO:0009205 3.97e-02 57/100 purine ribonucleoside triphosphate metabolic process
GO:0009207 3.97e-02 56/100 purine ribonucleoside triphosphate catabolic process
GO:0009259 3.97e-02 57/100 ribonucleotide metabolic process
GO:0009261 3.97e-02 56/100 ribonucleotide catabolic process
GO:0019693 3.97e-02 57/100 ribose phosphate metabolic process
GO:0034655 3.97e-02 73/100 nucleobase-containing compound catabolic process
GO:0042454 3.97e-02 56/100 ribonucleoside catabolic process
GO:0046128 3.97e-02 56/100 purine ribonucleoside metabolic process
GO:0046130 3.97e-02 56/100 purine ribonucleoside catabolic process
GO:0046434 3.97e-02 56/100 organophosphate catabolic process
GO:0046700 3.97e-02 74/100 heterocycle catabolic process
GO:0071704 3.97e-02 77/100 organic substance metabolic process
GO:0072521 3.97e-02 56/100 purine-containing compound metabolic process
GO:0072523 3.97e-02 56/100 purine-containing compound catabolic process
GO:1901136 3.97e-02 66/100 carbohydrate derivative catabolic process
GO:1901292 3.97e-02 56/100 nucleoside phosphate catabolic process
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Table A.5 – Table of overrepresented terms in pathogenic E. coli lineages (KS test).
ID qvalue Bootstrap Definition
GO:1901657 3.97e-02 59/100 glycosyl compound metabolic process
GO:1901658 3.97e-02 56/100 glycosyl compound catabolic process
GO:0006810 3.97e-02 65/100 transport
GO:0008150 3.97e-02 77/100 biological_process
GO:0009059 3.97e-02 70/100 macromolecule biosynthetic process
GO:0051234 3.97e-02 65/100 establishment of localization
GO:0016021 3.97e-02 81/100 integral component of membrane
GO:0031224 3.97e-02 81/100 intrinsic component of membrane
GO:0044425 3.97e-02 81/100 membrane part
GO:0000041 3.97e-02 61/100 transition metal ion transport
GO:0006022 3.97e-02 61/100 aminoglycan metabolic process
GO:0006351 3.97e-02 65/100 transcription, DNA-templated
GO:0010467 3.97e-02 67/100 gene expression
GO:0016070 3.97e-02 65/100 RNA metabolic process
GO:0032774 3.97e-02 65/100 RNA biosynthetic process
GO:0034654 3.97e-02 68/100 nucleobase-containing compound biosynthetic process
GO:0034755 3.97e-02 73/100 iron ion transmembrane transport
GO:0051188 3.97e-02 65/100 cofactor biosynthetic process
GO:0005575 3.97e-02 76/100 cellular_component
GO:0046903 3.97e-02 79/100 secretion
GO:0019835 3.97e-02 69/100 cytolysis
GO:0009057 3.97e-02 70/100 macromolecule catabolic process
GO:0009306 3.97e-02 77/100 protein secretion
GO:0009401 3.97e-02 75/100 phosphoenolpyruvate-dependent sugar phosphotransferase
system
GO:0010468 3.97e-02 70/100 regulation of gene expression
GO:0033554 3.97e-02 69/100 cellular response to stress
GO:0032940 3.97e-02 77/100 secretion by cell
GO:0060255 3.97e-02 70/100 regulation of macromolecule metabolic process
GO:0042742 4.06e-02 71/100 defense response to bacterium
GO:0032392 4.06e-02 66/100 DNA geometric change
GO:0032508 4.06e-02 66/100 DNA duplex unwinding
GO:0006184 4.19e-02 55/100 GTP catabolic process
GO:0046039 4.19e-02 55/100 GTP metabolic process
Table A.5: Overrepresented GO terms in pathogenic E. coli lin-
eages under Kolmogorov-Smirnov test, qvalue < 0.05.
A.2.4 Kolmogorov-Smirnov test (KO)
ID qvalue Bootstrap Definition
K01160 8.21e-04 95/100 rusA; crossover junction endodeoxyribonuclease RusA
[EC:3.1.22.4]
Table A.6: Overrepresented KO terms in pathogenic E. coli lin-
eages under Kolmogorov-Smirnov test, qvalue < 0.05.
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A.2.5 Wilcoxon-Mann-Whitney test (GO)
ID qvalue Bootstrap Definition
GO:0004252 4.19e-04 100/100 serine-type endopeptidase activity
GO:0009405 4.19e-04 100/100 pathogenesis
GO:0008821 4.76e-04 100/100 crossover junction endodeoxyribonuclease activity
GO:0016889 4.76e-04 100/100 endodeoxyribonuclease activity, producing 3’-
phosphomonoesters
GO:0016894 7.71e-04 99/100 endonuclease activity, active with either ribo- or deoxyri-
bonucleic acids and producing 3’-phosphomonoesters
GO:0051649 7.71e-04 100/100 establishment of localization in cell
GO:0051641 1.96e-03 99/100 cellular localization
GO:0008907 1.96e-03 97/100 integrase activity
GO:0019012 2.73e-03 100/100 virion
GO:0044423 2.73e-03 100/100 virion part
GO:0000737 2.73e-03 98/100 DNA catabolic process, endonucleolytic
GO:0019028 2.80e-03 99/100 viral capsid
GO:0016998 3.07e-03 97/100 cell wall macromolecule catabolic process
GO:0006308 3.43e-03 96/100 DNA catabolic process
GO:0090305 4.33e-03 97/100 nucleic acid phosphodiester bond hydrolysis
GO:0015074 4.33e-03 97/100 DNA integration
GO:0043086 5.71e-03 97/100 negative regulation of catalytic activity
GO:0004175 5.71e-03 90/100 endopeptidase activity
GO:0006826 6.03e-03 95/100 iron ion transport
GO:0034755 7.27e-03 94/100 iron ion transmembrane transport
GO:0009617 7.27e-03 95/100 response to bacterium
GO:0006184 7.27e-03 99/100 GTP catabolic process
GO:0003676 7.27e-03 89/100 nucleic acid binding
GO:0071103 7.27e-03 97/100 DNA conformation change
GO:0046903 7.27e-03 93/100 secretion
GO:0044718 7.27e-03 94/100 siderophore transmembrane transport
GO:0030001 7.27e-03 95/100 metal ion transport
GO:0042742 7.27e-03 95/100 defense response to bacterium
GO:0009306 7.40e-03 93/100 protein secretion
GO:0032940 7.40e-03 93/100 secretion by cell
GO:1901069 9.66e-03 96/100 guanosine-containing compound catabolic process
GO:0019867 1.08e-02 83/100 outer membrane
GO:0009279 1.13e-02 83/100 cell outer membrane
GO:0040029 1.22e-02 86/100 regulation of gene expression, epigenetic
GO:0044728 1.22e-02 86/100 DNA methylation or demethylation
GO:0006305 1.22e-02 86/100 DNA alkylation
GO:0006306 1.22e-02 86/100 DNA methylation
GO:0003677 1.28e-02 85/100 DNA binding
GO:0008236 1.41e-02 83/100 serine-type peptidase activity
GO:0017171 1.41e-02 83/100 serine hydrolase activity
GO:0006259 1.45e-02 81/100 DNA metabolic process
GO:0005488 1.47e-02 79/100 binding
GO:0097159 1.47e-02 80/100 organic cyclic compound binding
GO:1901363 1.47e-02 80/100 heterocyclic compound binding
GO:0006026 1.55e-02 85/100 aminoglycan catabolic process
GO:0043170 1.64e-02 77/100 macromolecule metabolic process
GO:0044260 1.80e-02 78/100 cellular macromolecule metabolic process
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Table A.7 – Table of overrepresented terms in pathogenic E. coli lineages (Wilcoxon).
ID qvalue Bootstrap Definition
GO:0008448 1.80e-02 80/100 N-acetylglucosamine-6-phosphate deacetylase activity
GO:0046039 1.80e-02 81/100 GTP metabolic process
GO:1901068 1.80e-02 81/100 guanosine-containing compound metabolic process
GO:0006807 1.81e-02 79/100 nitrogen compound metabolic process
GO:0090304 1.81e-02 78/100 nucleic acid metabolic process
GO:0009401 1.82e-02 81/100 phosphoenolpyruvate-dependent sugar phosphotransferase
system
GO:0032392 1.82e-02 89/100 DNA geometric change
GO:0032508 1.82e-02 89/100 DNA duplex unwinding
GO:0015891 1.82e-02 83/100 siderophore transport
GO:0034641 1.82e-02 79/100 cellular nitrogen compound metabolic process
GO:0030312 1.84e-02 76/100 external encapsulating structure
GO:0030313 1.85e-02 76/100 cell envelope
GO:0031975 1.85e-02 76/100 envelope
GO:0044270 1.85e-02 72/100 cellular nitrogen compound catabolic process
GO:0006139 1.85e-02 79/100 nucleobase-containing compound metabolic process
GO:0046483 1.85e-02 79/100 heterocycle metabolic process
GO:0006310 1.86e-02 77/100 DNA recombination
GO:0003674 1.86e-02 76/100 molecular_function
GO:0009276 1.86e-02 79/100 Gram-negative-bacterium-type cell wall
GO:0006027 1.93e-02 83/100 glycosaminoglycan catabolic process
GO:0009253 1.93e-02 83/100 peptidoglycan catabolic process
GO:0098660 1.93e-02 77/100 inorganic ion transmembrane transport
GO:0044238 2.02e-02 77/100 primary metabolic process
GO:0016021 2.02e-02 74/100 integral component of membrane
GO:0031224 2.02e-02 74/100 intrinsic component of membrane
GO:0000041 2.11e-02 79/100 transition metal ion transport
GO:0006508 2.11e-02 75/100 proteolysis
GO:0044462 2.11e-02 73/100 external encapsulating structure part
GO:0044425 2.11e-02 73/100 membrane part
GO:0015343 2.11e-02 79/100 siderophore transmembrane transporter activity
GO:0042927 2.11e-02 79/100 siderophore transporter activity
GO:0098655 2.15e-02 73/100 cation transmembrane transport
GO:0098662 2.15e-02 73/100 inorganic cation transmembrane transport
GO:0051346 2.26e-02 82/100 negative regulation of hydrolase activity
GO:0046700 2.35e-02 66/100 heterocycle catabolic process
GO:0034655 2.74e-02 66/100 nucleobase-containing compound catabolic process
GO:0016020 2.90e-02 74/100 membrane
GO:0071704 2.90e-02 69/100 organic substance metabolic process
GO:1901360 2.98e-02 72/100 organic cyclic compound metabolic process
GO:0008484 3.02e-02 76/100 sulfuric ester hydrolase activity
GO:0003796 3.05e-02 78/100 lysozyme activity
GO:0009007 3.05e-02 72/100 site-specific DNA-methyltransferase (adenine-specific) ac-
tivity
GO:0009987 3.06e-02 72/100 cellular process
GO:0051704 3.43e-02 69/100 multi-organism process
GO:0006725 3.43e-02 69/100 cellular aromatic compound metabolic process
GO:0004520 3.43e-02 70/100 endodeoxyribonuclease activity
GO:0044265 3.44e-02 71/100 cellular macromolecule catabolic process
GO:0008168 3.48e-02 68/100 methyltransferase activity
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Table A.7 – Table of overrepresented terms in pathogenic E. coli lineages (Wilcoxon).
ID qvalue Bootstrap Definition
GO:0008150 3.60e-02 67/100 biological_process
GO:0010911 3.60e-02 75/100 regulation of isomerase activity
GO:0032780 3.60e-02 75/100 negative regulation of ATPase activity
GO:2000371 3.60e-02 75/100 regulation of DNA topoisomerase (ATP-hydrolyzing) activ-
ity
GO:2000372 3.60e-02 75/100 negative regulation of DNA topoisomerase (ATP-
hydrolyzing) activity
GO:0019222 3.60e-02 67/100 regulation of metabolic process
GO:0006535 3.61e-02 77/100 cysteine biosynthetic process from serine
GO:0009001 3.61e-02 77/100 serine O-acetyltransferase activity
GO:0016412 3.61e-02 77/100 serine O-acyltransferase activity
GO:0009008 3.64e-02 67/100 DNA-methyltransferase activity
GO:0043167 3.71e-02 66/100 ion binding
GO:1901136 3.75e-02 56/100 carbohydrate derivative catabolic process
GO:0000287 3.75e-02 67/100 magnesium ion binding
GO:0070011 3.96e-02 70/100 peptidase activity, acting on L-amino acid peptides
GO:0036094 3.97e-02 68/100 small molecule binding
GO:0005576 4.16e-02 67/100 extracellular region
GO:0009057 4.26e-02 66/100 macromolecule catabolic process
GO:0008152 4.30e-02 63/100 metabolic process
GO:0005575 4.56e-02 66/100 cellular_component
GO:0065007 4.56e-02 67/100 biological regulation
GO:0071944 4.56e-02 63/100 cell periphery
GO:0001882 4.56e-02 62/100 nucleoside binding
GO:0097367 4.56e-02 63/100 carbohydrate derivative binding
GO:0044237 4.56e-02 64/100 cellular metabolic process
GO:0000166 4.56e-02 65/100 nucleotide binding
GO:1901265 4.56e-02 65/100 nucleoside phosphate binding
GO:0050708 4.56e-02 72/100 regulation of protein secretion
GO:0051046 4.56e-02 72/100 regulation of secretion
GO:0019835 4.76e-02 65/100 cytolysis
GO:0016741 4.78e-02 60/100 transferase activity, transferring one-carbon groups
Table A.7: Overrepresented GO terms in pathogenic E. coli lin-
eages under Wilcoxon-Mann-Whitney U test, qvalue < 0.05.
A.2.6 Wilcoxon-Mann-Whitney test (KO)
ID qvalue Bootstrap Definition
K01160 5.53e-04 99/100 rusA; crossover junction endodeoxyribonuclease RusA
[EC:3.1.22.4]
K15536 9.40e-03 91/100 cybC; soluble cytochrome b562
K14744 9.40e-03 95/100 rzpD; prophage endopeptidase [EC:3.4.-.-]
K07001 9.40e-03 94/100 K07001; NTE family protein
K02557 9.40e-03 90/100 motB; chemotaxis protein MotB
K02812 9.40e-03 84/100 PTS-Sor-EIIA, sorF; PTS system, sorbose-specific IIA compo-
nent [EC:2.7.1.69]
K02814 9.40e-03 84/100 PTS-Sor-EIIC, sorA; PTS system, sorbose-specific IIC compo-
nent
K16076 1.70e-02 89/100 nmpC, ompD; outer membrane porin protein LC
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Table A.8 – Overrepresented KO terms in pathgenic E. coli lineages (Wilcoxon).
ID qvalue Bootstrap Definition
K00068 1.70e-02 79/100 srlD; sorbitol-6-phosphate 2-dehydrogenase [EC:1.1.1.140]
K02813 1.70e-02 79/100 PTS-Sor-EIIB, sorB; PTS system, sorbose-specific IIB compo-
nent [EC:2.7.1.69]
K06889 1.81e-02 85/100 K06889
K06934 1.81e-02 80/100 K06934
K16785 1.81e-02 80/100 ecfT; energy-coupling factor transport system permease protein
K16786 1.81e-02 80/100 ecfA1; energy-coupling factor transport system ATP-binding
protein [EC:3.6.3.-]
K16923 1.81e-02 80/100 qrtT; energy-coupling factor transport system substrate-specific
component
K01061 1.81e-02 76/100 E3.1.1.45; carboxymethylenebutenolidase [EC:3.1.1.45]
K01185 2.25e-02 78/100 E3.2.1.17; lysozyme [EC:3.2.1.17]
K02815 2.25e-02 77/100 PTS-Sor-EIID, sorM; PTS system, sorbose-specific IID compo-
nent
K06221 2.31e-02 80/100 dkgA; 2,5-diketo-D-gluconate reductase A [EC:1.1.1.346]
K02744 2.45e-02 73/100 PTS-Aga-EIIA, agaF; PTS system, N-acetylgalactosamine-
specific IIA component [EC:2.7.1.69]
K02747 2.45e-02 73/100 PTS-Aga-EIID, agaE; PTS system, N-acetylgalactosamine-
specific IID component
K01652 2.45e-02 73/100 E2.2.1.6L, ilvB, ilvG, ilvI; acetolactate synthase I/II/III large
subunit [EC:2.2.1.6]
K12684 2.87e-02 73/100 esp, sigA, sepA; serine protease autotransporter [EC:3.4.21.-]
K02014 2.87e-02 71/100 TC.FEV.OM; iron complex outermembrane recepter protein
K11911 3.11e-02 75/100 vasL; type VI secretion system protein VasL
K07491 3.21e-02 78/100 K07491; putative transposase
K02042 3.44e-02 65/100 phnE; phosphonate transport system permease protein
K16087 3.72e-02 73/100 TC.FEV.OM3, tbpA, hemR, lbpA, hpuB, bhuR, hugA, hmbR;
hemoglobin/transferrin/lactoferrin receptor protein
K02436 3.85e-02 67/100 gatR; DeoR family transcriptional regulator, galactitol utiliza-
tion operon repressor
K02013 4.16e-02 67/100 ABC.FEV.A; iron complex transport system ATP-binding pro-
tein [EC:3.6.3.34]
K03222 4.16e-02 69/100 yscJ, sctJ, hrcJ; type III secretion protein J
K07052 4.16e-02 74/100 K07052
K07017 4.16e-02 67/100 K07017
K00375 4.16e-02 64/100 K00375; GntR family transcriptional regulator / MocR family
aminotransferase
K04783 4.16e-02 62/100 irp5, ybtE; yersiniabactin salicyl-AMP ligase [EC:6.3.2.-]
K04784 4.16e-02 62/100 irp2, HMWP2; yersiniabactin nonribosomal peptide synthetase
K04785 4.16e-02 62/100 irp3, ybtU; yersiniabactin synthetase, thiazolinyl reductase com-
ponent
K05372 4.16e-02 62/100 ybtA; AraC family transcriptional regulator
K05373 4.16e-02 62/100 ybtX, irp8; MFS transporter, putative signal transducer
K06147 4.16e-02 62/100 ABCB-BAC; ATP-binding cassette, subfamily B, bacterial
K15721 4.16e-02 62/100 fyuA; pesticin/yersiniabactin receptor
K02495 4.16e-02 66/100 hemN, hemZ; oxygen-independent coproporphyrinogen III oxi-
dase [EC:1.3.99.22]
K04786 4.16e-02 62/100 irp1, HMWP1; yersiniabactin nonribosomal peptide/polyketide
synthase
K07225 4.16e-02 66/100 hmuS; putative hemin transport protein
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Table A.8 – Overrepresented KO terms in pathgenic E. coli lineages (Wilcoxon).
ID qvalue Bootstrap Definition
K07227 4.16e-02 66/100 chuX; hypothetical protein
K07243 4.38e-02 65/100 FTR, efeU; high-affinity iron transporter
K11892 4.38e-02 63/100 impK, ompA, vasF, dotU; type VI secretion system protein
ImpK
K11907 4.38e-02 63/100 vasG, clpV; type VI secretion system protein VasG
K03227 4.83e-02 61/100 yscS, sctS, hrcS; type III secretion protein S
K16089 4.83e-02 57/100 TC.FEV.OM2, fepA, iroN, cirA, pfeA, cfrA, hmuR; outer mem-
brane receptor for ferrienterochelin and colicins
K02016 4.83e-02 60/100 ABC.FEV.S; iron complex transport system substrate-binding
protein
K16787 4.96e-02 58/100 ecfA2; energy-coupling factor transport system ATP-binding
protein [EC:3.6.3.-]
Table A.8: Overrepresented KO terms in pathogenic E. coli lin-
eages under Wilcoxon-Mann-Whitney test, qvalue < 0.05.
A.3 Additional images
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Figure A.1: Heatmap for the 25 most significant GO terms (qvaule < 0.05, KS test).
The pattern of the heatmap seen in Figure 5.3 involving EHEC/EPEC lineages isn’t
observable in this heatmap, with these strains not forming a separate group. Green
parts indicate low normalized frequency of a term (below 2 standard deviations), red
indicates high normalized frequency (above 2 standard deviations). The blue/red bar on
the left indicates whether the lineage is pathogenic (blue, test group) or free-living (red,
background group).
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Figure A.2: Heatmap for the 25 most significant GO terms (qvaule < 0.05, Wilcoxon-
Mann-Whitney test). Similarly with the heatmap for the KS test, the pattern of the
heatmap seen in Figure 5.3 isn’t observable in this heatmap, with these strains not form-
ing a unique group. Green parts indicate low normalized frequency of a term (below 2
standard deviations), red indicates high normalized frequency (above 2 standard devia-
tions). The blue/red bar on the left indicates whether the lineage is pathogenic (blue,
test group) or free-living (red, background group).
